Adamis Pharmaceuticals Corporation

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ZTS has a market cap of 70.91B. Regarding current trading prices, ADMP is priced at $0.78, while ZTS trades at $159.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ZTS's P/E ratio is 28.59. In terms of profitability, ADMP's ROE is +0.00%, compared to ZTS's ROE of +0.50%. Regarding short-term risk, ADMP is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MKKGY has a market cap of 60.76B. Regarding current trading prices, ADMP is priced at $0.78, while MKKGY trades at $28.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MKKGY's P/E ratio is 19.32. In terms of profitability, ADMP's ROE is +0.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ADMP is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MKGAF has a market cap of 59.42B. Regarding current trading prices, ADMP is priced at $0.78, while MKGAF trades at $136.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MKGAF's P/E ratio is 18.90. In terms of profitability, ADMP's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ADMP is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HLNCF has a market cap of 48.85B. Regarding current trading prices, ADMP is priced at $0.78, while HLNCF trades at $5.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HLNCF's P/E ratio is 25.79. In terms of profitability, ADMP's ROE is +0.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ADMP is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HLN has a market cap of 48.44B. Regarding current trading prices, ADMP is priced at $0.78, while HLN trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HLN's P/E ratio is 25.57. In terms of profitability, ADMP's ROE is +0.00%, compared to HLN's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TKPHF has a market cap of 46.97B. Regarding current trading prices, ADMP is priced at $0.78, while TKPHF trades at $29.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TKPHF's P/E ratio is 33.17. In terms of profitability, ADMP's ROE is +0.00%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, ADMP is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TAK has a market cap of 45.28B. Regarding current trading prices, ADMP is priced at $0.78, while TAK trades at $14.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TAK's P/E ratio is 31.92. In terms of profitability, ADMP's ROE is +0.00%, compared to TAK's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IPSEY has a market cap of 38.92B. Regarding current trading prices, ADMP is priced at $0.78, while IPSEY trades at $29.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IPSEY's P/E ratio is 25.35. In terms of profitability, ADMP's ROE is +0.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, ADMP is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SDZNY has a market cap of 19.69B. Regarding current trading prices, ADMP is priced at $0.78, while SDZNY trades at $45.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SDZNY's P/E ratio is -2286.00. In terms of profitability, ADMP's ROE is +0.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TEVA has a market cap of 19.40B. Regarding current trading prices, ADMP is priced at $0.78, while TEVA trades at $16.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TEVA's P/E ratio is -14.73. In terms of profitability, ADMP's ROE is +0.00%, compared to TEVA's ROE of -0.26%. Regarding short-term risk, ADMP is less volatile compared to TEVA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, ADMP is priced at $0.78, while TEVJF trades at $16.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, ADMP's ROE is +0.00%, compared to TEVJF's ROE of -0.26%. Regarding short-term risk, ADMP is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, ADMP is priced at $0.78, while ESALY trades at $61.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ADMP's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SGIOY has a market cap of 14.44B. Regarding current trading prices, ADMP is priced at $0.78, while SGIOY trades at $8.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SGIOY's P/E ratio is 12.48. In terms of profitability, ADMP's ROE is +0.00%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, ADMP is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ITCI has a market cap of 14.05B. Regarding current trading prices, ADMP is priced at $0.78, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ITCI's P/E ratio is -180.64. In terms of profitability, ADMP's ROE is +0.00%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, ADMP is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, ADMP is priced at $0.78, while SGIOF trades at $15.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, ADMP's ROE is +0.00%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, ADMP is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CTLT has a market cap of 11.52B. Regarding current trading prices, ADMP is priced at $0.78, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CTLT's P/E ratio is -27.84. In terms of profitability, ADMP's ROE is +0.00%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, ADMP is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NBIX has a market cap of 11.45B. Regarding current trading prices, ADMP is priced at $0.78, while NBIX trades at $115.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NBIX's P/E ratio is 39.09. In terms of profitability, ADMP's ROE is +0.00%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, ADMP is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RDY has a market cap of 11.18B. Regarding current trading prices, ADMP is priced at $0.78, while RDY trades at $13.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RDY's P/E ratio is 17.66. In terms of profitability, ADMP's ROE is +0.00%, compared to RDY's ROE of +0.18%. Regarding short-term risk, ADMP is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, ADMP is priced at $0.78, while BIOVF trades at $30.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOVF's P/E ratio is 25.85. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, ADMP is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VTRS has a market cap of 10.40B. Regarding current trading prices, ADMP is priced at $0.78, while VTRS trades at $8.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VTRS's P/E ratio is -16.55. In terms of profitability, ADMP's ROE is +0.00%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, ADMP is less volatile compared to VTRS. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, ADMP is priced at $0.78, while IPSEF trades at $125.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IPSEF's P/E ratio is 25.74. In terms of profitability, ADMP's ROE is +0.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, ADMP is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SFOSF has a market cap of 8.61B. Regarding current trading prices, ADMP is priced at $0.78, while SFOSF trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, ADMP's ROE is +0.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ESALF has a market cap of 7.87B. Regarding current trading prices, ADMP is priced at $0.78, while ESALF trades at $27.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ESALF's P/E ratio is 19.38. In terms of profitability, ADMP's ROE is +0.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ADMP is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ESAIY has a market cap of 7.87B. Regarding current trading prices, ADMP is priced at $0.78, while ESAIY trades at $6.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ESAIY's P/E ratio is 19.22. In terms of profitability, ADMP's ROE is +0.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ADMP is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GZPHF has a market cap of 6.27B. Regarding current trading prices, ADMP is priced at $0.78, while GZPHF trades at $2.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, ADMP's ROE is +0.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ADMP is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ELAN has a market cap of 5.94B. Regarding current trading prices, ADMP is priced at $0.78, while ELAN trades at $11.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ELAN's P/E ratio is 15.96. In terms of profitability, ADMP's ROE is +0.00%, compared to ELAN's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HKMPF has a market cap of 5.94B. Regarding current trading prices, ADMP is priced at $0.78, while HKMPF trades at $26.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HKMPF's P/E ratio is 16.73. In terms of profitability, ADMP's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ADMP is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HKMPY has a market cap of 5.93B. Regarding current trading prices, ADMP is priced at $0.78, while HKMPY trades at $53.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HKMPY's P/E ratio is 16.70. In terms of profitability, ADMP's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ADMP is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LNTH has a market cap of 5.66B. Regarding current trading prices, ADMP is priced at $0.78, while LNTH trades at $81.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LNTH's P/E ratio is 18.75. In terms of profitability, ADMP's ROE is +0.00%, compared to LNTH's ROE of +0.29%. Regarding short-term risk, ADMP is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, ADMP is priced at $0.78, while APNHF trades at $12.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas APNHF's P/E ratio is 20.07. In terms of profitability, ADMP's ROE is +0.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, WIBFF has a market cap of 4.96B. Regarding current trading prices, ADMP is priced at $0.78, while WIBFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RGC has a market cap of 4.76B. Regarding current trading prices, ADMP is priced at $0.78, while RGC trades at $366.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RGC's P/E ratio is -1143.78. In terms of profitability, ADMP's ROE is +0.00%, compared to RGC's ROE of -0.25%. Regarding short-term risk, ADMP is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, ADMP is priced at $0.78, while HLBBF trades at $5.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, ADMP's ROE is +0.00%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ADMP is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LVZPF has a market cap of 4.01B. Regarding current trading prices, ADMP is priced at $0.78, while LVZPF trades at $3.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, ADMP's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ADMP is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PRGO has a market cap of 3.71B. Regarding current trading prices, ADMP is priced at $0.78, while PRGO trades at $27.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PRGO's P/E ratio is -22.50. In terms of profitability, ADMP's ROE is +0.00%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, ADMP is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AMRX has a market cap of 3.45B. Regarding current trading prices, ADMP is priced at $0.78, while AMRX trades at $7.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AMRX's P/E ratio is -185.25. In terms of profitability, ADMP's ROE is +0.00%, compared to AMRX's ROE of -0.00%. Regarding short-term risk, ADMP is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HLUBF has a market cap of 3.41B. Regarding current trading prices, ADMP is priced at $0.78, while HLUBF trades at $3.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, ADMP's ROE is +0.00%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ADMP is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EVO has a market cap of 3.05B. Regarding current trading prices, ADMP is priced at $0.78, while EVO trades at $4.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EVO's P/E ratio is -6.52. In terms of profitability, ADMP's ROE is +0.00%, compared to EVO's ROE of -0.19%. Regarding short-term risk, ADMP is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, ADMP is priced at $0.78, while INVVY trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ADMP's ROE is +0.00%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, ADMP is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, APNHY has a market cap of 3.00B. Regarding current trading prices, ADMP is priced at $0.78, while APNHY trades at $6.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas APNHY's P/E ratio is 12.28. In terms of profitability, ADMP's ROE is +0.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ALVO has a market cap of 2.92B. Regarding current trading prices, ADMP is priced at $0.78, while ALVO trades at $9.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ALVO's P/E ratio is -11.14. In terms of profitability, ADMP's ROE is +0.00%, compared to ALVO's ROE of +0.46%. Regarding short-term risk, ADMP is less volatile compared to ALVO. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, ADMP is priced at $0.78, while IZQVF trades at $20.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ADMP's ROE is +0.00%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, ADMP is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, ADMP is priced at $0.78, while HMDCF trades at $3.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, ADMP's ROE is +0.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ALVOW has a market cap of 2.77B. Regarding current trading prices, ADMP is priced at $0.78, while ALVOW trades at $1.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ALVOW's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to ALVOW's ROE of +0.46%. Regarding short-term risk, ADMP is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, ADMP is priced at $0.78, while DNPUF trades at $6.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DNPUF's P/E ratio is -2.12. In terms of profitability, ADMP's ROE is +0.00%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, ADMP is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HCM has a market cap of 2.56B. Regarding current trading prices, ADMP is priced at $0.78, while HCM trades at $14.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HCM's P/E ratio is 71.05. In terms of profitability, ADMP's ROE is +0.00%, compared to HCM's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, ADMP is priced at $0.78, while ULIHF trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, ADMP is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HYPMY has a market cap of 2.49B. Regarding current trading prices, ADMP is priced at $0.78, while HYPMY trades at $3.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HYPMY's P/E ratio is 17.91. In terms of profitability, ADMP's ROE is +0.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ADMP is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, THCBF has a market cap of 2.37B. Regarding current trading prices, ADMP is priced at $0.78, while THCBF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas THCBF's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, ADMP is priced at $0.78, while HTSUF trades at $32.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HTSUF's P/E ratio is 15.68. In terms of profitability, ADMP's ROE is +0.00%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, ADMP is priced at $0.78, while CHSYF trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, ADMP's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DCPH has a market cap of 2.21B. Regarding current trading prices, ADMP is priced at $0.78, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DCPH's P/E ratio is -11.58. In terms of profitability, ADMP's ROE is +0.00%, compared to DCPH's ROE of -0.52%. Regarding short-term risk, ADMP is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TSMRF has a market cap of 2.14B. Regarding current trading prices, ADMP is priced at $0.78, while TSMRF trades at $28.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, ADMP's ROE is +0.00%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, ADMP is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, ADMP is priced at $0.78, while DMPHF trades at $39.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DMPHF's P/E ratio is 16.55. In terms of profitability, ADMP's ROE is +0.00%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, ADMP is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, ADMP is priced at $0.78, while LJUIF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ADMP's ROE is +0.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, ADMP is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, ADMP is priced at $0.78, while LBTSF trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, ADMP's ROE is +0.00%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ADMP is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EMBCV has a market cap of 1.91B. Regarding current trading prices, ADMP is priced at $0.78, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EMBCV's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to EMBCV's ROE of -0.08%. Regarding short-term risk, ADMP is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SUPN has a market cap of 1.77B. Regarding current trading prices, ADMP is priced at $0.78, while SUPN trades at $31.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SUPN's P/E ratio is 24.02. In terms of profitability, ADMP's ROE is +0.00%, compared to SUPN's ROE of +0.08%. Regarding short-term risk, ADMP is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NPNKF has a market cap of 1.77B. Regarding current trading prices, ADMP is priced at $0.78, while NPNKF trades at $26.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NPNKF's P/E ratio is 8.35. In terms of profitability, ADMP's ROE is +0.00%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BHC has a market cap of 1.69B. Regarding current trading prices, ADMP is priced at $0.78, while BHC trades at $4.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BHC's P/E ratio is -38.21. In terms of profitability, ADMP's ROE is +0.00%, compared to BHC's ROE of +0.05%. Regarding short-term risk, ADMP is less volatile compared to BHC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, ADMP is priced at $0.78, while SHEZF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ADMP's ROE is +0.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ADMP is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, ADMP is priced at $0.78, while CHIZF trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, ADMP's ROE is +0.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BGM has a market cap of 1.69B. Regarding current trading prices, ADMP is priced at $0.78, while BGM trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BGM's P/E ratio is -58.00. In terms of profitability, ADMP's ROE is +0.00%, compared to BGM's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, ADMP is priced at $0.78, while SMDPY trades at $4.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SMDPY's P/E ratio is -1.32. In terms of profitability, ADMP's ROE is +0.00%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, ADMP is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TARO has a market cap of 1.62B. Regarding current trading prices, ADMP is priced at $0.78, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TARO's P/E ratio is 30.05. In terms of profitability, ADMP's ROE is +0.00%, compared to TARO's ROE of +0.03%. Regarding short-term risk, ADMP is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NPPNY has a market cap of 1.59B. Regarding current trading prices, ADMP is priced at $0.78, while NPPNY trades at $5.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NPPNY's P/E ratio is 7.46. In terms of profitability, ADMP's ROE is +0.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AUSAF has a market cap of 1.59B. Regarding current trading prices, ADMP is priced at $0.78, while AUSAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AUSAF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to AUSAF's ROE of -1.15%. Regarding short-term risk, ADMP is less volatile compared to AUSAF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, ADMP is priced at $0.78, while KARBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ADMP's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, ADMP is priced at $0.78, while EVOTF trades at $8.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, ADMP's ROE is +0.00%, compared to EVOTF's ROE of -0.19%. Regarding short-term risk, ADMP is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, YIHCF has a market cap of 1.46B. Regarding current trading prices, ADMP is priced at $0.78, while YIHCF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ADMP's ROE is +0.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, ADMP is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, ADMP is priced at $0.78, while ARSUF trades at $20.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, ADMP's ROE is +0.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, ADMP is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ANIP has a market cap of 1.43B. Regarding current trading prices, ADMP is priced at $0.78, while ANIP trades at $66.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ANIP's P/E ratio is -63.75. In terms of profitability, ADMP's ROE is +0.00%, compared to ANIP's ROE of -0.04%. Regarding short-term risk, ADMP is less volatile compared to ANIP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INDV has a market cap of 1.38B. Regarding current trading prices, ADMP is priced at $0.78, while INDV trades at $11.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INDV's P/E ratio is -221.60. In terms of profitability, ADMP's ROE is +0.00%, compared to INDV's ROE of -0.01%. Regarding short-term risk, ADMP is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GTBIF has a market cap of 1.33B. Regarding current trading prices, ADMP is priced at $0.78, while GTBIF trades at $5.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GTBIF's P/E ratio is 18.65. In terms of profitability, ADMP's ROE is +0.00%, compared to GTBIF's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GNMLF has a market cap of 1.24B. Regarding current trading prices, ADMP is priced at $0.78, while GNMLF trades at $1.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GNMLF's P/E ratio is 11.27. In terms of profitability, ADMP's ROE is +0.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ADMP is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PCRX has a market cap of 1.16B. Regarding current trading prices, ADMP is priced at $0.78, while PCRX trades at $25.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PCRX's P/E ratio is -11.68. In terms of profitability, ADMP's ROE is +0.00%, compared to PCRX's ROE of -0.12%. Regarding short-term risk, ADMP is less volatile compared to PCRX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, ADMP is priced at $0.78, while SWGHF trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SWGHF's P/E ratio is 13.71. In terms of profitability, ADMP's ROE is +0.00%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, ADMP is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AMPH has a market cap of 1.15B. Regarding current trading prices, ADMP is priced at $0.78, while AMPH trades at $24.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AMPH's P/E ratio is 7.88. In terms of profitability, ADMP's ROE is +0.00%, compared to AMPH's ROE of +0.22%. Regarding short-term risk, ADMP is less volatile compared to AMPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DVAX has a market cap of 1.13B. Regarding current trading prices, ADMP is priced at $0.78, while DVAX trades at $9.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DVAX's P/E ratio is -18.82. In terms of profitability, ADMP's ROE is +0.00%, compared to DVAX's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOGY has a market cap of 1.12B. Regarding current trading prices, ADMP is priced at $0.78, while BIOGY trades at $10.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOGY's P/E ratio is 33.78. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOGY's ROE of +0.20%. Regarding short-term risk, ADMP is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NIKA has a market cap of 1.03B. Regarding current trading prices, ADMP is priced at $0.78, while NIKA trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NIKA's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to NIKA's ROE of +0.63%. Regarding short-term risk, ADMP is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KKPCF has a market cap of 1.01B. Regarding current trading prices, ADMP is priced at $0.78, while KKPCF trades at $26.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KKPCF's P/E ratio is 7.10. In terms of profitability, ADMP's ROE is +0.00%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, ADMP is priced at $0.78, while KSPHF trades at $23.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KSPHF's P/E ratio is 12.16. In terms of profitability, ADMP's ROE is +0.00%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CASBF has a market cap of 979.87M. Regarding current trading prices, ADMP is priced at $0.78, while CASBF trades at $3.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CASBF's P/E ratio is -15.24. In terms of profitability, ADMP's ROE is +0.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, ADMP is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, COLL has a market cap of 928.29M. Regarding current trading prices, ADMP is priced at $0.78, while COLL trades at $28.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas COLL's P/E ratio is 15.53. In terms of profitability, ADMP's ROE is +0.00%, compared to COLL's ROE of +0.31%. Regarding short-term risk, ADMP is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PETQ has a market cap of 919.17M. Regarding current trading prices, ADMP is priced at $0.78, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PETQ's P/E ratio is 83.73. In terms of profitability, ADMP's ROE is +0.00%, compared to PETQ's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PAHC has a market cap of 910.12M. Regarding current trading prices, ADMP is priced at $0.78, while PAHC trades at $22.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PAHC's P/E ratio is 46.81. In terms of profitability, ADMP's ROE is +0.00%, compared to PAHC's ROE of +0.07%. Regarding short-term risk, ADMP is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AVDL has a market cap of 907.37M. Regarding current trading prices, ADMP is priced at $0.78, while AVDL trades at $9.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AVDL's P/E ratio is -18.41. In terms of profitability, ADMP's ROE is +0.00%, compared to AVDL's ROE of -0.66%. Regarding short-term risk, ADMP is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HROW has a market cap of 895.12M. Regarding current trading prices, ADMP is priced at $0.78, while HROW trades at $24.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HROW's P/E ratio is -49.80. In terms of profitability, ADMP's ROE is +0.00%, compared to HROW's ROE of -0.28%. Regarding short-term risk, ADMP is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LVTTF has a market cap of 886.81M. Regarding current trading prices, ADMP is priced at $0.78, while LVTTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EVRRF has a market cap of 883.00M. Regarding current trading prices, ADMP is priced at $0.78, while EVRRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, ADMP's ROE is +0.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ADMP is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TCNNF has a market cap of 841.70M. Regarding current trading prices, ADMP is priced at $0.78, while TCNNF trades at $4.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TCNNF's P/E ratio is -5.58. In terms of profitability, ADMP's ROE is +0.00%, compared to TCNNF's ROE of -0.12%. Regarding short-term risk, ADMP is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NRXCF has a market cap of 837.83M. Regarding current trading prices, ADMP is priced at $0.78, while NRXCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ADMP's ROE is +0.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ADMP is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, ADMP is priced at $0.78, while TWAPF trades at $16.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TWAPF's P/E ratio is 6.16. In terms of profitability, ADMP's ROE is +0.00%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, ADMP is priced at $0.78, while CSWYF trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, ADMP's ROE is +0.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, ADMP is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CRON has a market cap of 763.13M. Regarding current trading prices, ADMP is priced at $0.78, while CRON trades at $1.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CRON's P/E ratio is 18.00. In terms of profitability, ADMP's ROE is +0.00%, compared to CRON's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EMBC has a market cap of 695.87M. Regarding current trading prices, ADMP is priced at $0.78, while EMBC trades at $11.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EMBC's P/E ratio is 12.09. In terms of profitability, ADMP's ROE is +0.00%, compared to EMBC's ROE of -0.08%. Regarding short-term risk, ADMP is less volatile compared to EMBC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, ADMP is priced at $0.78, while TRXPF trades at $24.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ADMP's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ADMP is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, ADMP is priced at $0.78, while SWDCF trades at $4.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, ADMP's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ADMP is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EOLS has a market cap of 631.86M. Regarding current trading prices, ADMP is priced at $0.78, while EOLS trades at $9.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EOLS's P/E ratio is -12.10. In terms of profitability, ADMP's ROE is +0.00%, compared to EOLS's ROE of -4.10%. Regarding short-term risk, ADMP is less volatile compared to EOLS. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CURLF has a market cap of 621.88M. Regarding current trading prices, ADMP is priced at $0.78, while CURLF trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CURLF's P/E ratio is -2.66. In terms of profitability, ADMP's ROE is +0.00%, compared to CURLF's ROE of -0.24%. Regarding short-term risk, ADMP is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, ADMP is priced at $0.78, while TRSSF trades at $1.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ADMP's ROE is +0.00%, compared to TRSSF's ROE of -0.43%. Regarding short-term risk, ADMP is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BDSI has a market cap of 577.05M. Regarding current trading prices, ADMP is priced at $0.78, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BDSI's P/E ratio is 6.82. In terms of profitability, ADMP's ROE is +0.00%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, ADMP is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SGFEF has a market cap of 544.13M. Regarding current trading prices, ADMP is priced at $0.78, while SGFEF trades at $102.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, ADMP's ROE is +0.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, ADMP is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, ADMP is priced at $0.78, while CCHWF trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ADMP's ROE is +0.00%, compared to CCHWF's ROE of -0.42%. Regarding short-term risk, ADMP is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, ADMP is priced at $0.78, while AIHLF trades at $3.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, ADMP's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ADMP is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, ADMP is priced at $0.78, while BOIRF trades at $28.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, ADMP's ROE is +0.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, ADMP is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ZYBT has a market cap of 488.61M. Regarding current trading prices, ADMP is priced at $0.78, while ZYBT trades at $10.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ZYBT's P/E ratio is 171.83. In terms of profitability, ADMP's ROE is +0.00%, compared to ZYBT's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, ADMP is priced at $0.78, while PEXXF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ADMP's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ELTP has a market cap of 459.36M. Regarding current trading prices, ADMP is priced at $0.78, while ELTP trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ELTP's P/E ratio is -21.50. In terms of profitability, ADMP's ROE is +0.00%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, ADMP is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, ADMP is priced at $0.78, while SHPHF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, ADMP's ROE is +0.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, ADMP is priced at $0.78, while MITPF trades at $6.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MITPF's P/E ratio is -3.05. In terms of profitability, ADMP's ROE is +0.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ADMP is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KHTRF has a market cap of 443.54M. Regarding current trading prices, ADMP is priced at $0.78, while KHTRF trades at $4.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KHTRF's P/E ratio is 148.67. In terms of profitability, ADMP's ROE is +0.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ADMP is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TLRY has a market cap of 431.73M. Regarding current trading prices, ADMP is priced at $0.78, while TLRY trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TLRY's P/E ratio is -0.39. In terms of profitability, ADMP's ROE is +0.00%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, ADMP is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, ADMP is priced at $0.78, while AGYTF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, ADMP's ROE is +0.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, ADMP is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KMDA has a market cap of 393.05M. Regarding current trading prices, ADMP is priced at $0.78, while KMDA trades at $6.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KMDA's P/E ratio is 27.34. In terms of profitability, ADMP's ROE is +0.00%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SIGA has a market cap of 390.58M. Regarding current trading prices, ADMP is priced at $0.78, while SIGA trades at $5.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SIGA's P/E ratio is 4.56. In terms of profitability, ADMP's ROE is +0.00%, compared to SIGA's ROE of +0.33%. Regarding short-term risk, ADMP is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ORGO has a market cap of 388.17M. Regarding current trading prices, ADMP is priced at $0.78, while ORGO trades at $3.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ORGO's P/E ratio is -306.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ORGO's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to ORGO. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TKNO has a market cap of 371.95M. Regarding current trading prices, ADMP is priced at $0.78, while TKNO trades at $6.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TKNO's P/E ratio is -12.21. In terms of profitability, ADMP's ROE is +0.00%, compared to TKNO's ROE of -0.32%. Regarding short-term risk, ADMP is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SNDL has a market cap of 331.92M. Regarding current trading prices, ADMP is priced at $0.78, while SNDL trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SNDL's P/E ratio is -4.30. In terms of profitability, ADMP's ROE is +0.00%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, ADMP is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EBS has a market cap of 307.00M. Regarding current trading prices, ADMP is priced at $0.78, while EBS trades at $5.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EBS's P/E ratio is -1.57. In terms of profitability, ADMP's ROE is +0.00%, compared to EBS's ROE of -0.37%. Regarding short-term risk, ADMP is less volatile compared to EBS. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GLASF has a market cap of 306.74M. Regarding current trading prices, ADMP is priced at $0.78, while GLASF trades at $6.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GLASF's P/E ratio is -29.00. In terms of profitability, ADMP's ROE is +0.00%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ALIM has a market cap of 301.29M. Regarding current trading prices, ADMP is priced at $0.78, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ALIM's P/E ratio is 5.28. In terms of profitability, ADMP's ROE is +0.00%, compared to ALIM's ROE of -0.34%. Regarding short-term risk, ADMP is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, UBQU has a market cap of 290.82M. Regarding current trading prices, ADMP is priced at $0.78, while UBQU trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas UBQU's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to UBQU's ROE of -0.38%. Regarding short-term risk, ADMP is less volatile compared to UBQU. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PKBFF has a market cap of 288.49M. Regarding current trading prices, ADMP is priced at $0.78, while PKBFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ADMP is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AQST has a market cap of 277.11M. Regarding current trading prices, ADMP is priced at $0.78, while AQST trades at $2.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AQST's P/E ratio is -5.47. In terms of profitability, ADMP's ROE is +0.00%, compared to AQST's ROE of +1.00%. Regarding short-term risk, ADMP is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, ADMP is priced at $0.78, while BHCCF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ADMP's ROE is +0.00%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, ADMP is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACB has a market cap of 266.19M. Regarding current trading prices, ADMP is priced at $0.78, while ACB trades at $4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACB's P/E ratio is 24.25. In terms of profitability, ADMP's ROE is +0.00%, compared to ACB's ROE of -0.06%. Regarding short-term risk, ADMP is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LNDC has a market cap of 263.63M. Regarding current trading prices, ADMP is priced at $0.78, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LNDC's P/E ratio is -4.04. In terms of profitability, ADMP's ROE is +0.00%, compared to LNDC's ROE of -0.65%. Regarding short-term risk, ADMP is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VRNOF has a market cap of 262.59M. Regarding current trading prices, ADMP is priced at $0.78, while VRNOF trades at $0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VRNOF's P/E ratio is -0.74. In terms of profitability, ADMP's ROE is +0.00%, compared to VRNOF's ROE of -0.24%. Regarding short-term risk, ADMP is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LFCR has a market cap of 258.07M. Regarding current trading prices, ADMP is priced at $0.78, while LFCR trades at $6.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LFCR's P/E ratio is -4.74. In terms of profitability, ADMP's ROE is +0.00%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, ADMP is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CPHRF has a market cap of 255.37M. Regarding current trading prices, ADMP is priced at $0.78, while CPHRF trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CPHRF's P/E ratio is 21.67. In terms of profitability, ADMP's ROE is +0.00%, compared to CPHRF's ROE of +0.12%. Regarding short-term risk, ADMP is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CRLBF has a market cap of 252.96M. Regarding current trading prices, ADMP is priced at $0.78, while CRLBF trades at $0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CRLBF's P/E ratio is -3.41. In terms of profitability, ADMP's ROE is +0.00%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, ADMP is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CGC has a market cap of 237.23M. Regarding current trading prices, ADMP is priced at $0.78, while CGC trades at $1.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CGC's P/E ratio is -0.36. In terms of profitability, ADMP's ROE is +0.00%, compared to CGC's ROE of -0.88%. Regarding short-term risk, ADMP is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TYHT has a market cap of 229.17M. Regarding current trading prices, ADMP is priced at $0.78, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TYHT's P/E ratio is -1.61. In terms of profitability, ADMP's ROE is +0.00%, compared to TYHT's ROE of -0.84%. Regarding short-term risk, ADMP is less volatile compared to TYHT. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, ADMP is priced at $0.78, while PLNHF trades at $0.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ADMP's ROE is +0.00%, compared to PLNHF's ROE of +0.01%. Regarding short-term risk, ADMP is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, REPH has a market cap of 177.42M. Regarding current trading prices, ADMP is priced at $0.78, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas REPH's P/E ratio is -8.04. In terms of profitability, ADMP's ROE is +0.00%, compared to REPH's ROE of -0.15%. Regarding short-term risk, ADMP is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DERM has a market cap of 159.07M. Regarding current trading prices, ADMP is priced at $0.78, while DERM trades at $6.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DERM's P/E ratio is -9.56. In terms of profitability, ADMP's ROE is +0.00%, compared to DERM's ROE of -1.06%. Regarding short-term risk, ADMP is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ESPR has a market cap of 158.16M. Regarding current trading prices, ADMP is priced at $0.78, while ESPR trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ESPR's P/E ratio is -2.85. In terms of profitability, ADMP's ROE is +0.00%, compared to ESPR's ROE of +0.15%. Regarding short-term risk, ADMP is less volatile compared to ESPR. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OGI has a market cap of 148.98M. Regarding current trading prices, ADMP is priced at $0.78, while OGI trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OGI's P/E ratio is -3.37. In terms of profitability, ADMP's ROE is +0.00%, compared to OGI's ROE of -0.18%. Regarding short-term risk, ADMP is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, ADMP is priced at $0.78, while HUMDF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, ADMP's ROE is +0.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, ADMP is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOA has a market cap of 144.83M. Regarding current trading prices, ADMP is priced at $0.78, while BIOA trades at $4.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOA's P/E ratio is -0.61. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOA's ROE of -1.12%. Regarding short-term risk, ADMP is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, ADMP is priced at $0.78, while COPHF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ADMP is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, THTX has a market cap of 120.47M. Regarding current trading prices, ADMP is priced at $0.78, while THTX trades at $2.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas THTX's P/E ratio is -37.43. In terms of profitability, ADMP's ROE is +0.00%, compared to THTX's ROE of +0.16%. Regarding short-term risk, ADMP is less volatile compared to THTX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PHCUF has a market cap of 117.10M. Regarding current trading prices, ADMP is priced at $0.78, while PHCUF trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PHCUF's P/E ratio is -432.00. In terms of profitability, ADMP's ROE is +0.00%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, ADMP is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SCTL has a market cap of 116.13M. Regarding current trading prices, ADMP is priced at $0.78, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SCTL's P/E ratio is -7.86. In terms of profitability, ADMP's ROE is +0.00%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, ADMP is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IRWD has a market cap of 114.75M. Regarding current trading prices, ADMP is priced at $0.78, while IRWD trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IRWD's P/E ratio is -3.73. In terms of profitability, ADMP's ROE is +0.00%, compared to IRWD's ROE of -0.09%. Regarding short-term risk, ADMP is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PROC has a market cap of 113.95M. Regarding current trading prices, ADMP is priced at $0.78, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PROC's P/E ratio is 1.53. In terms of profitability, ADMP's ROE is +0.00%, compared to PROC's ROE of -2.22%. Regarding short-term risk, ADMP is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, ADMP is priced at $0.78, while LPCUF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ADMP's ROE is +0.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ADMP is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, ADMP is priced at $0.78, while CNVCF trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ADMP's ROE is +0.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, ADMP is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRUSF has a market cap of 106.95M. Regarding current trading prices, ADMP is priced at $0.78, while GRUSF trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRUSF's P/E ratio is -8.63. In terms of profitability, ADMP's ROE is +0.00%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, ADMP is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, ADMP is priced at $0.78, while HLTRF trades at $3.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HLTRF's P/E ratio is -5.19. In terms of profitability, ADMP's ROE is +0.00%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ADMP is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ZOM has a market cap of 95.35M. Regarding current trading prices, ADMP is priced at $0.78, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ZOM's P/E ratio is -1.62. In terms of profitability, ADMP's ROE is +0.00%, compared to ZOM's ROE of -0.28%. Regarding short-term risk, ADMP is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OPTN has a market cap of 95.10M. Regarding current trading prices, ADMP is priced at $0.78, while OPTN trades at $9.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OPTN's P/E ratio is -4.43. In terms of profitability, ADMP's ROE is +0.00%, compared to OPTN's ROE of +0.39%. Regarding short-term risk, ADMP is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CRDL has a market cap of 94.20M. Regarding current trading prices, ADMP is priced at $0.78, while CRDL trades at $1.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CRDL's P/E ratio is -3.08. In terms of profitability, ADMP's ROE is +0.00%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, ADMP is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, ADMP is priced at $0.78, while ABSCF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, ADMP is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOYF has a market cap of 89.47M. Regarding current trading prices, ADMP is priced at $0.78, while BIOYF trades at $7.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOYF's P/E ratio is 17.33. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, ADMP is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRVI has a market cap of 88.91M. Regarding current trading prices, ADMP is priced at $0.78, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRVI's P/E ratio is 26.05. In terms of profitability, ADMP's ROE is +0.00%, compared to GRVI's ROE of -2.44%. Regarding short-term risk, ADMP is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PLNH has a market cap of 84.57M. Regarding current trading prices, ADMP is priced at $0.78, while PLNH trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PLNH's P/E ratio is -1.62. In terms of profitability, ADMP's ROE is +0.00%, compared to PLNH's ROE of -0.36%. Regarding short-term risk, ADMP is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LOVFF has a market cap of 83.94M. Regarding current trading prices, ADMP is priced at $0.78, while LOVFF trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LOVFF's P/E ratio is 9.26. In terms of profitability, ADMP's ROE is +0.00%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, ADMP is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, ADMP is priced at $0.78, while GBLP trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GBLP's P/E ratio is -0.67. In terms of profitability, ADMP's ROE is +0.00%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, ADMP is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LRDSF has a market cap of 83.46M. Regarding current trading prices, ADMP is priced at $0.78, while LRDSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ADMP is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBWTF has a market cap of 82.39M. Regarding current trading prices, ADMP is priced at $0.78, while CBWTF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBWTF's P/E ratio is -6.27. In terms of profitability, ADMP's ROE is +0.00%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, ADMP is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, JUSHF has a market cap of 76.71M. Regarding current trading prices, ADMP is priced at $0.78, while JUSHF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas JUSHF's P/E ratio is -1.56. In terms of profitability, ADMP's ROE is +0.00%, compared to JUSHF's ROE of +1.44%. Regarding short-term risk, ADMP is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AAWH has a market cap of 75.91M. Regarding current trading prices, ADMP is priced at $0.78, while AAWH trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AAWH's P/E ratio is -0.92. In terms of profitability, ADMP's ROE is +0.00%, compared to AAWH's ROE of -0.83%. Regarding short-term risk, ADMP is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INCR has a market cap of 74.99M. Regarding current trading prices, ADMP is priced at $0.78, while INCR trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INCR's P/E ratio is -3.88. In terms of profitability, ADMP's ROE is +0.00%, compared to INCR's ROE of -0.07%. Regarding short-term risk, ADMP is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, ADMP is priced at $0.78, while EOFBY trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ADMP's ROE is +0.00%, compared to EOFBY's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ZYNE has a market cap of 70.12M. Regarding current trading prices, ADMP is priced at $0.78, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, ADMP's ROE is +0.00%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, ADMP is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MEDXF has a market cap of 67.76M. Regarding current trading prices, ADMP is priced at $0.78, while MEDXF trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MEDXF's P/E ratio is 14.00. In terms of profitability, ADMP's ROE is +0.00%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, ADMP is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SSIC has a market cap of 66.72M. Regarding current trading prices, ADMP is priced at $0.78, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SSIC's P/E ratio is 11.93. In terms of profitability, ADMP's ROE is +0.00%, compared to SSIC's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CPIX has a market cap of 65.65M. Regarding current trading prices, ADMP is priced at $0.78, while CPIX trades at $4.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CPIX's P/E ratio is -10.22. In terms of profitability, ADMP's ROE is +0.00%, compared to CPIX's ROE of -0.26%. Regarding short-term risk, ADMP is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VLNS has a market cap of 61.46M. Regarding current trading prices, ADMP is priced at $0.78, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VLNS's P/E ratio is -1.03. In terms of profitability, ADMP's ROE is +0.00%, compared to VLNS's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GDNSF has a market cap of 61.05M. Regarding current trading prices, ADMP is priced at $0.78, while GDNSF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, ADMP's ROE is +0.00%, compared to GDNSF's ROE of +1.60%. Regarding short-term risk, ADMP is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DUTV has a market cap of 58.71M. Regarding current trading prices, ADMP is priced at $0.78, while DUTV trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DUTV's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, ADMP is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ASRT has a market cap of 58.42M. Regarding current trading prices, ADMP is priced at $0.78, while ASRT trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ASRT's P/E ratio is -2.65. In terms of profitability, ADMP's ROE is +0.00%, compared to ASRT's ROE of -0.17%. Regarding short-term risk, ADMP is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MDDVF has a market cap of 57.19M. Regarding current trading prices, ADMP is priced at $0.78, while MDDVF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MDDVF's P/E ratio is -2.31. In terms of profitability, ADMP's ROE is +0.00%, compared to MDDVF's ROE of -0.68%. Regarding short-term risk, ADMP is less volatile compared to MDDVF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SRUTF has a market cap of 52.68M. Regarding current trading prices, ADMP is priced at $0.78, while SRUTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SRUTF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, ADMP is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KHRNF has a market cap of 51.93M. Regarding current trading prices, ADMP is priced at $0.78, while KHRNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KHRNF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, ADMP is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ORXOY has a market cap of 50.90M. Regarding current trading prices, ADMP is priced at $0.78, while ORXOY trades at $1.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ORXOY's P/E ratio is -2.42. In terms of profitability, ADMP's ROE is +0.00%, compared to ORXOY's ROE of +11.95%. Regarding short-term risk, ADMP is less volatile compared to ORXOY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, JUPW has a market cap of 49.33M. Regarding current trading prices, ADMP is priced at $0.78, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas JUPW's P/E ratio is -2.41. In terms of profitability, ADMP's ROE is +0.00%, compared to JUPW's ROE of -0.06%. Regarding short-term risk, ADMP is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DXBRF has a market cap of 47.84M. Regarding current trading prices, ADMP is priced at $0.78, while DXBRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DXBRF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to DXBRF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to DXBRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ETST has a market cap of 44.61M. Regarding current trading prices, ADMP is priced at $0.78, while ETST trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ETST's P/E ratio is 15.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ETST's ROE of +0.78%. Regarding short-term risk, ADMP is less volatile compared to ETST. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SYMQY has a market cap of 43.05M. Regarding current trading prices, ADMP is priced at $0.78, while SYMQY trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SYMQY's P/E ratio is -1.53. In terms of profitability, ADMP's ROE is +0.00%, compared to SYMQY's ROE of -0.39%. Regarding short-term risk, ADMP is less volatile compared to SYMQY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INNPF has a market cap of 40.62M. Regarding current trading prices, ADMP is priced at $0.78, while INNPF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INNPF's P/E ratio is -14.00. In terms of profitability, ADMP's ROE is +0.00%, compared to INNPF's ROE of -0.38%. Regarding short-term risk, ADMP is less volatile compared to INNPF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NLVVF has a market cap of 38.80M. Regarding current trading prices, ADMP is priced at $0.78, while NLVVF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NLVVF's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to NLVVF's ROE of +148.22%. Regarding short-term risk, ADMP is more volatile compared to NLVVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, QLI has a market cap of 38.68M. Regarding current trading prices, ADMP is priced at $0.78, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas QLI's P/E ratio is -4.92. In terms of profitability, ADMP's ROE is +0.00%, compared to QLI's ROE of -0.16%. Regarding short-term risk, ADMP is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RMTI has a market cap of 38.28M. Regarding current trading prices, ADMP is priced at $0.78, while RMTI trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RMTI's P/E ratio is -37.33. In terms of profitability, ADMP's ROE is +0.00%, compared to RMTI's ROE of -0.02%. Regarding short-term risk, ADMP is less volatile compared to RMTI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ORXOF has a market cap of 37.27M. Regarding current trading prices, ADMP is priced at $0.78, while ORXOF trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ORXOF's P/E ratio is -3.86. In terms of profitability, ADMP's ROE is +0.00%, compared to ORXOF's ROE of +11.95%. Regarding short-term risk, ADMP is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MRMD has a market cap of 36.93M. Regarding current trading prices, ADMP is priced at $0.78, while MRMD trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MRMD's P/E ratio is -3.17. In terms of profitability, ADMP's ROE is +0.00%, compared to MRMD's ROE of -0.18%. Regarding short-term risk, ADMP is more volatile compared to MRMD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SCYX has a market cap of 36.76M. Regarding current trading prices, ADMP is priced at $0.78, while SCYX trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SCYX's P/E ratio is -2.14. In terms of profitability, ADMP's ROE is +0.00%, compared to SCYX's ROE of -0.34%. Regarding short-term risk, ADMP is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHIEF has a market cap of 35.42M. Regarding current trading prices, ADMP is priced at $0.78, while SHIEF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHIEF's P/E ratio is -0.68. In terms of profitability, ADMP's ROE is +0.00%, compared to SHIEF's ROE of -4.70%. Regarding short-term risk, ADMP is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CSWYY has a market cap of 34.99M. Regarding current trading prices, ADMP is priced at $0.78, while CSWYY trades at $18.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CSWYY's P/E ratio is 4.60. In terms of profitability, ADMP's ROE is +0.00%, compared to CSWYY's ROE of +0.12%. Regarding short-term risk, ADMP is less volatile compared to CSWYY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HDRPF has a market cap of 32.85M. Regarding current trading prices, ADMP is priced at $0.78, while HDRPF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HDRPF's P/E ratio is -1.00. In terms of profitability, ADMP's ROE is +0.00%, compared to HDRPF's ROE of -0.13%. Regarding short-term risk, ADMP is less volatile compared to HDRPF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AYRWF has a market cap of 31.76M. Regarding current trading prices, ADMP is priced at $0.78, while AYRWF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AYRWF's P/E ratio is -0.08. In terms of profitability, ADMP's ROE is +0.00%, compared to AYRWF's ROE of -0.68%. Regarding short-term risk, ADMP is less volatile compared to AYRWF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HEXO has a market cap of 31.24M. Regarding current trading prices, ADMP is priced at $0.78, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HEXO's P/E ratio is -0.26. In terms of profitability, ADMP's ROE is +0.00%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, ADMP is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PMXSF has a market cap of 31.04M. Regarding current trading prices, ADMP is priced at $0.78, while PMXSF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PMXSF's P/E ratio is 2.60. In terms of profitability, ADMP's ROE is +0.00%, compared to PMXSF's ROE of -1.09%. Regarding short-term risk, ADMP is more volatile compared to PMXSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNTMF has a market cap of 28.75M. Regarding current trading prices, ADMP is priced at $0.78, while CNTMF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNTMF's P/E ratio is -0.35. In terms of profitability, ADMP's ROE is +0.00%, compared to CNTMF's ROE of +35.76%. Regarding short-term risk, ADMP is less volatile compared to CNTMF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBSTF has a market cap of 28.72M. Regarding current trading prices, ADMP is priced at $0.78, while CBSTF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBSTF's P/E ratio is -0.26. In terms of profitability, ADMP's ROE is +0.00%, compared to CBSTF's ROE of -6.64%. Regarding short-term risk, ADMP is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DBCCF has a market cap of 28.67M. Regarding current trading prices, ADMP is priced at $0.78, while DBCCF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DBCCF's P/E ratio is 2.49. In terms of profitability, ADMP's ROE is +0.00%, compared to DBCCF's ROE of +0.12%. Regarding short-term risk, ADMP is more volatile compared to DBCCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SXTC has a market cap of 26.70M. Regarding current trading prices, ADMP is priced at $0.78, while SXTC trades at $1.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SXTC's P/E ratio is 0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, ADMP is less volatile compared to SXTC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ITHUF has a market cap of 25.63M. Regarding current trading prices, ADMP is priced at $0.78, while ITHUF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ITHUF's P/E ratio is -0.38. In terms of profitability, ADMP's ROE is +0.00%, compared to ITHUF's ROE of +0.10%. Regarding short-term risk, ADMP is less volatile compared to ITHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GENH has a market cap of 25.34M. Regarding current trading prices, ADMP is priced at $0.78, while GENH trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GENH's P/E ratio is -2.24. In terms of profitability, ADMP's ROE is +0.00%, compared to GENH's ROE of +78.73%. Regarding short-term risk, ADMP is more volatile compared to GENH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MEDIF has a market cap of 25.10M. Regarding current trading prices, ADMP is priced at $0.78, while MEDIF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MEDIF's P/E ratio is -2.07. In terms of profitability, ADMP's ROE is +0.00%, compared to MEDIF's ROE of -0.25%. Regarding short-term risk, ADMP is less volatile compared to MEDIF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EGRX has a market cap of 24.62M. Regarding current trading prices, ADMP is priced at $0.78, while EGRX trades at $1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EGRX's P/E ratio is 2.24. In terms of profitability, ADMP's ROE is +0.00%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, ADMP is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHBRF has a market cap of 24.45M. Regarding current trading prices, ADMP is priced at $0.78, while CHBRF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHBRF's P/E ratio is -2.42. In terms of profitability, ADMP's ROE is +0.00%, compared to CHBRF's ROE of -3.55%. Regarding short-term risk, ADMP is less volatile compared to CHBRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INIS has a market cap of 23.68M. Regarding current trading prices, ADMP is priced at $0.78, while INIS trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INIS's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to INIS's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to INIS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CYTH has a market cap of 23.59M. Regarding current trading prices, ADMP is priced at $0.78, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CYTH's P/E ratio is -0.80. In terms of profitability, ADMP's ROE is +0.00%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, ADMP is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MILFF has a market cap of 22.86M. Regarding current trading prices, ADMP is priced at $0.78, while MILFF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MILFF's P/E ratio is 19.42. In terms of profitability, ADMP's ROE is +0.00%, compared to MILFF's ROE of +0.06%. Regarding short-term risk, ADMP is less volatile compared to MILFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GHBWF has a market cap of 22.67M. Regarding current trading prices, ADMP is priced at $0.78, while GHBWF trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GHBWF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GHBWF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to GHBWF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DRRX has a market cap of 22.66M. Regarding current trading prices, ADMP is priced at $0.78, while DRRX trades at $0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DRRX's P/E ratio is -1.22. In terms of profitability, ADMP's ROE is +0.00%, compared to DRRX's ROE of -1.41%. Regarding short-term risk, ADMP is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VYYRF has a market cap of 22.35M. Regarding current trading prices, ADMP is priced at $0.78, while VYYRF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VYYRF's P/E ratio is -13.85. In terms of profitability, ADMP's ROE is +0.00%, compared to VYYRF's ROE of -1.62%. Regarding short-term risk, ADMP is more volatile compared to VYYRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KALA has a market cap of 22.07M. Regarding current trading prices, ADMP is priced at $0.78, while KALA trades at $3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KALA's P/E ratio is -0.34. In terms of profitability, ADMP's ROE is +0.00%, compared to KALA's ROE of -3.89%. Regarding short-term risk, ADMP is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, QNTM has a market cap of 20.87M. Regarding current trading prices, ADMP is priced at $0.78, while QNTM trades at $9.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas QNTM's P/E ratio is -0.69. In terms of profitability, ADMP's ROE is +0.00%, compared to QNTM's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VNNYF has a market cap of 20.57M. Regarding current trading prices, ADMP is priced at $0.78, while VNNYF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VNNYF's P/E ratio is -14.93. In terms of profitability, ADMP's ROE is +0.00%, compared to VNNYF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to VNNYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AVCNF has a market cap of 20.13M. Regarding current trading prices, ADMP is priced at $0.78, while AVCNF trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AVCNF's P/E ratio is -3.00. In terms of profitability, ADMP's ROE is +0.00%, compared to AVCNF's ROE of -3.82%. Regarding short-term risk, ADMP is more volatile compared to AVCNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRAMF has a market cap of 20.12M. Regarding current trading prices, ADMP is priced at $0.78, while GRAMF trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRAMF's P/E ratio is -0.08. In terms of profitability, ADMP's ROE is +0.00%, compared to GRAMF's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to GRAMF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VEXTF has a market cap of 20.05M. Regarding current trading prices, ADMP is priced at $0.78, while VEXTF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VEXTF's P/E ratio is -1.01. In terms of profitability, ADMP's ROE is +0.00%, compared to VEXTF's ROE of -0.27%. Regarding short-term risk, ADMP is more volatile compared to VEXTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ATHJF has a market cap of 19.64M. Regarding current trading prices, ADMP is priced at $0.78, while ATHJF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ATHJF's P/E ratio is -1.20. In terms of profitability, ADMP's ROE is +0.00%, compared to ATHJF's ROE of -1.09%. Regarding short-term risk, ADMP is less volatile compared to ATHJF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RDDTF has a market cap of 19.44M. Regarding current trading prices, ADMP is priced at $0.78, while RDDTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RDDTF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to RDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BFFTF has a market cap of 19.35M. Regarding current trading prices, ADMP is priced at $0.78, while BFFTF trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BFFTF's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to BFFTF's ROE of +0.02%. Regarding short-term risk, ADMP is less volatile compared to BFFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CXXIF has a market cap of 18.73M. Regarding current trading prices, ADMP is priced at $0.78, while CXXIF trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CXXIF's P/E ratio is -5.20. In terms of profitability, ADMP's ROE is +0.00%, compared to CXXIF's ROE of -0.15%. Regarding short-term risk, ADMP is more volatile compared to CXXIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TGPHF has a market cap of 18.45M. Regarding current trading prices, ADMP is priced at $0.78, while TGPHF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TGPHF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TGPHF's ROE of -0.15%. Regarding short-term risk, ADMP is more volatile compared to TGPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ROMJF has a market cap of 18.22M. Regarding current trading prices, ADMP is priced at $0.78, while ROMJF trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ROMJF's P/E ratio is -10.70. In terms of profitability, ADMP's ROE is +0.00%, compared to ROMJF's ROE of -0.07%. Regarding short-term risk, ADMP is more volatile compared to ROMJF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, YOURF has a market cap of 17.82M. Regarding current trading prices, ADMP is priced at $0.78, while YOURF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas YOURF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to YOURF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to YOURF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, WLDFF has a market cap of 17.02M. Regarding current trading prices, ADMP is priced at $0.78, while WLDFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas WLDFF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, ADMP is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TXMD has a market cap of 16.90M. Regarding current trading prices, ADMP is priced at $0.78, while TXMD trades at $1.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TXMD's P/E ratio is -7.30. In terms of profitability, ADMP's ROE is +0.00%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, ADMP is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NXSCF has a market cap of 16.07M. Regarding current trading prices, ADMP is priced at $0.78, while NXSCF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NXSCF's P/E ratio is -1.37. In terms of profitability, ADMP's ROE is +0.00%, compared to NXSCF's ROE of -2.40%. Regarding short-term risk, ADMP is less volatile compared to NXSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NXTTF has a market cap of 15.76M. Regarding current trading prices, ADMP is priced at $0.78, while NXTTF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NXTTF's P/E ratio is -1.24. In terms of profitability, ADMP's ROE is +0.00%, compared to NXTTF's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to NXTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HMPSF has a market cap of 15.68M. Regarding current trading prices, ADMP is priced at $0.78, while HMPSF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HMPSF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HMPSF's ROE of -80.61%. Regarding short-term risk, ADMP is more volatile compared to HMPSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RAMMF has a market cap of 15.16M. Regarding current trading prices, ADMP is priced at $0.78, while RAMMF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RAMMF's P/E ratio is -1.38. In terms of profitability, ADMP's ROE is +0.00%, compared to RAMMF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to RAMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PKANF has a market cap of 14.81M. Regarding current trading prices, ADMP is priced at $0.78, while PKANF trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PKANF's P/E ratio is -0.71. In terms of profitability, ADMP's ROE is +0.00%, compared to PKANF's ROE of -2.07%. Regarding short-term risk, ADMP is more volatile compared to PKANF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACRX has a market cap of 14.58M. Regarding current trading prices, ADMP is priced at $0.78, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACRX's P/E ratio is -0.31. In terms of profitability, ADMP's ROE is +0.00%, compared to ACRX's ROE of -0.40%. Regarding short-term risk, ADMP is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SISI has a market cap of 14.41M. Regarding current trading prices, ADMP is priced at $0.78, while SISI trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SISI's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to SISI's ROE of -0.84%. Regarding short-term risk, ADMP is less volatile compared to SISI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RWBYF has a market cap of 13.71M. Regarding current trading prices, ADMP is priced at $0.78, while RWBYF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RWBYF's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to RWBYF's ROE of +1.95%. Regarding short-term risk, ADMP is more volatile compared to RWBYF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VDRM has a market cap of 13.50M. Regarding current trading prices, ADMP is priced at $0.78, while VDRM trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VDRM's P/E ratio is 0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to VDRM's ROE of -2.48%. Regarding short-term risk, ADMP is less volatile compared to VDRM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CWBHF has a market cap of 13.48M. Regarding current trading prices, ADMP is priced at $0.78, while CWBHF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CWBHF's P/E ratio is -0.45. In terms of profitability, ADMP's ROE is +0.00%, compared to CWBHF's ROE of -0.85%. Regarding short-term risk, ADMP is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FLGC has a market cap of 13.19M. Regarding current trading prices, ADMP is priced at $0.78, while FLGC trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FLGC's P/E ratio is -0.52. In terms of profitability, ADMP's ROE is +0.00%, compared to FLGC's ROE of -3.31%. Regarding short-term risk, ADMP is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHHE has a market cap of 13.11M. Regarding current trading prices, ADMP is priced at $0.78, while CHHE trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHHE's P/E ratio is -10.00. In terms of profitability, ADMP's ROE is +0.00%, compared to CHHE's ROE of +0.25%. Regarding short-term risk, ADMP is less volatile compared to CHHE. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GELS has a market cap of 12.93M. Regarding current trading prices, ADMP is priced at $0.78, while GELS trades at $1.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GELS's P/E ratio is -5.71. In terms of profitability, ADMP's ROE is +0.00%, compared to GELS's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PRPH has a market cap of 12.69M. Regarding current trading prices, ADMP is priced at $0.78, while PRPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PRPH's P/E ratio is -0.13. In terms of profitability, ADMP's ROE is +0.00%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, ADMP is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MGCLF has a market cap of 12.11M. Regarding current trading prices, ADMP is priced at $0.78, while MGCLF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MGCLF's P/E ratio is -0.12. In terms of profitability, ADMP's ROE is +0.00%, compared to MGCLF's ROE of -1.04%. Regarding short-term risk, ADMP is more volatile compared to MGCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHALF has a market cap of 11.63M. Regarding current trading prices, ADMP is priced at $0.78, while CHALF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHALF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNGGF has a market cap of 11.60M. Regarding current trading prices, ADMP is priced at $0.78, while CNGGF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNGGF's P/E ratio is -0.27. In terms of profitability, ADMP's ROE is +0.00%, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, ADMP is less volatile compared to CNGGF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, COSM has a market cap of 11.46M. Regarding current trading prices, ADMP is priced at $0.78, while COSM trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas COSM's P/E ratio is -0.36. In terms of profitability, ADMP's ROE is +0.00%, compared to COSM's ROE of -0.51%. Regarding short-term risk, ADMP is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MRVFF has a market cap of 11.15M. Regarding current trading prices, ADMP is priced at $0.78, while MRVFF trades at $0.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MRVFF's P/E ratio is -19.59. In terms of profitability, ADMP's ROE is +0.00%, compared to MRVFF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to MRVFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TLPH has a market cap of 11.07M. Regarding current trading prices, ADMP is priced at $0.78, while TLPH trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TLPH's P/E ratio is -1.08. In terms of profitability, ADMP's ROE is +0.00%, compared to TLPH's ROE of -1.11%. Regarding short-term risk, ADMP is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNPOF has a market cap of 10.96M. Regarding current trading prices, ADMP is priced at $0.78, while CNPOF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNPOF's P/E ratio is -0.24. In terms of profitability, ADMP's ROE is +0.00%, compared to CNPOF's ROE of -0.92%. Regarding short-term risk, ADMP is less volatile compared to CNPOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AGRX has a market cap of 10.43M. Regarding current trading prices, ADMP is priced at $0.78, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AGRX's P/E ratio is -0.89. In terms of profitability, ADMP's ROE is +0.00%, compared to AGRX's ROE of +1.04%. Regarding short-term risk, ADMP is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HYEX has a market cap of 10.01M. Regarding current trading prices, ADMP is priced at $0.78, while HYEX trades at $3.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HYEX's P/E ratio is -11.96. In terms of profitability, ADMP's ROE is +0.00%, compared to HYEX's ROE of -1.90%. Regarding short-term risk, ADMP is more volatile compared to HYEX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RAFA has a market cap of 9.32M. Regarding current trading prices, ADMP is priced at $0.78, while RAFA trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RAFA's P/E ratio is -7.14. In terms of profitability, ADMP's ROE is +0.00%, compared to RAFA's ROE of +0.02%. Regarding short-term risk, ADMP is less volatile compared to RAFA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BLMH has a market cap of 9.08M. Regarding current trading prices, ADMP is priced at $0.78, while BLMH trades at $0.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BLMH's P/E ratio is -0.67. In terms of profitability, ADMP's ROE is +0.00%, compared to BLMH's ROE of -1.22%. Regarding short-term risk, ADMP is more volatile compared to BLMH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MSTH has a market cap of 9.06M. Regarding current trading prices, ADMP is priced at $0.78, while MSTH trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MSTH's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to MSTH's ROE of -0.22%. Regarding short-term risk, ADMP is more volatile compared to MSTH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BFRIW has a market cap of 8.90M. Regarding current trading prices, ADMP is priced at $0.78, while BFRIW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BFRIW's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to BFRIW's ROE of -4.60%. Regarding short-term risk, ADMP is more volatile compared to BFRIW. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TRUFF has a market cap of 8.74M. Regarding current trading prices, ADMP is priced at $0.78, while TRUFF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TRUFF's P/E ratio is -2.18. In terms of profitability, ADMP's ROE is +0.00%, compared to TRUFF's ROE of -0.33%. Regarding short-term risk, ADMP is less volatile compared to TRUFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ELIXF has a market cap of 8.60M. Regarding current trading prices, ADMP is priced at $0.78, while ELIXF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ELIXF's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to ELIXF's ROE of +0.27%. Regarding short-term risk, ADMP is more volatile compared to ELIXF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TPPRF has a market cap of 8.45M. Regarding current trading prices, ADMP is priced at $0.78, while TPPRF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TPPRF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TPPRF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to TPPRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NLTX has a market cap of 8.20M. Regarding current trading prices, ADMP is priced at $0.78, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NLTX's P/E ratio is -0.28. In terms of profitability, ADMP's ROE is +0.00%, compared to NLTX's ROE of -0.09%. Regarding short-term risk, ADMP is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CPIVF has a market cap of 8.19M. Regarding current trading prices, ADMP is priced at $0.78, while CPIVF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CPIVF's P/E ratio is -1.40. In terms of profitability, ADMP's ROE is +0.00%, compared to CPIVF's ROE of -0.79%. Regarding short-term risk, ADMP is more volatile compared to CPIVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FLWPF has a market cap of 8.10M. Regarding current trading prices, ADMP is priced at $0.78, while FLWPF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FLWPF's P/E ratio is -0.12. In terms of profitability, ADMP's ROE is +0.00%, compared to FLWPF's ROE of -1.44%. Regarding short-term risk, ADMP is less volatile compared to FLWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOE has a market cap of 8.06M. Regarding current trading prices, ADMP is priced at $0.78, while BIOE trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOE's P/E ratio is -5.30. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOE's ROE of +0.70%. Regarding short-term risk, ADMP is more volatile compared to BIOE. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AYTU has a market cap of 7.71M. Regarding current trading prices, ADMP is priced at $0.78, while AYTU trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AYTU's P/E ratio is -0.60. In terms of profitability, ADMP's ROE is +0.00%, compared to AYTU's ROE of -0.18%. Regarding short-term risk, ADMP is less volatile compared to AYTU. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LVRLF has a market cap of 7.69M. Regarding current trading prices, ADMP is priced at $0.78, while LVRLF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LVRLF's P/E ratio is -7.00. In terms of profitability, ADMP's ROE is +0.00%, compared to LVRLF's ROE of +0.26%. Regarding short-term risk, ADMP is less volatile compared to LVRLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNFHF has a market cap of 7.66M. Regarding current trading prices, ADMP is priced at $0.78, while CNFHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNFHF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CNFHF's ROE of -7.84%. Regarding short-term risk, ADMP is less volatile compared to CNFHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RVVTF has a market cap of 7.66M. Regarding current trading prices, ADMP is priced at $0.78, while RVVTF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RVVTF's P/E ratio is -1.83. In terms of profitability, ADMP's ROE is +0.00%, compared to RVVTF's ROE of -0.70%. Regarding short-term risk, ADMP is less volatile compared to RVVTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBIH has a market cap of 7.65M. Regarding current trading prices, ADMP is priced at $0.78, while CBIH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBIH's P/E ratio is 0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to CBIH's ROE of +0.53%. Regarding short-term risk, ADMP is less volatile compared to CBIH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CRRTF has a market cap of 7.41M. Regarding current trading prices, ADMP is priced at $0.78, while CRRTF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CRRTF's P/E ratio is -3.90. In terms of profitability, ADMP's ROE is +0.00%, compared to CRRTF's ROE of -0.16%. Regarding short-term risk, ADMP is more volatile compared to CRRTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LCI has a market cap of 7.38M. Regarding current trading prices, ADMP is priced at $0.78, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LCI's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to LCI's ROE of +1.66%. Regarding short-term risk, ADMP is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BGXX has a market cap of 7.26M. Regarding current trading prices, ADMP is priced at $0.78, while BGXX trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BGXX's P/E ratio is -0.76. In terms of profitability, ADMP's ROE is +0.00%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, ADMP is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CLCFF has a market cap of 7.21M. Regarding current trading prices, ADMP is priced at $0.78, while CLCFF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CLCFF's P/E ratio is 3.20. In terms of profitability, ADMP's ROE is +0.00%, compared to CLCFF's ROE of +0.11%. Regarding short-term risk, ADMP is more volatile compared to CLCFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IGPK has a market cap of 7.07M. Regarding current trading prices, ADMP is priced at $0.78, while IGPK trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IGPK's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to IGPK's ROE of +0.02%. Regarding short-term risk, ADMP is less volatile compared to IGPK. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CPHI has a market cap of 6.90M. Regarding current trading prices, ADMP is priced at $0.78, while CPHI trades at $2.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CPHI's P/E ratio is -0.78. In terms of profitability, ADMP's ROE is +0.00%, compared to CPHI's ROE of -0.63%. Regarding short-term risk, ADMP is less volatile compared to CPHI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AVTBF has a market cap of 6.82M. Regarding current trading prices, ADMP is priced at $0.78, while AVTBF trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AVTBF's P/E ratio is -0.42. In terms of profitability, ADMP's ROE is +0.00%, compared to AVTBF's ROE of -0.53%. Regarding short-term risk, ADMP is more volatile compared to AVTBF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BFRI has a market cap of 6.63M. Regarding current trading prices, ADMP is priced at $0.78, while BFRI trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BFRI's P/E ratio is -0.22. In terms of profitability, ADMP's ROE is +0.00%, compared to BFRI's ROE of -4.60%. Regarding short-term risk, ADMP is less volatile compared to BFRI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CRYM has a market cap of 6.40M. Regarding current trading prices, ADMP is priced at $0.78, while CRYM trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CRYM's P/E ratio is -0.90. In terms of profitability, ADMP's ROE is +0.00%, compared to CRYM's ROE of +1.10%. Regarding short-term risk, ADMP is less volatile compared to CRYM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OILFF has a market cap of 6.39M. Regarding current trading prices, ADMP is priced at $0.78, while OILFF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OILFF's P/E ratio is -3.84. In terms of profitability, ADMP's ROE is +0.00%, compared to OILFF's ROE of -0.22%. Regarding short-term risk, ADMP is less volatile compared to OILFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MVMDF has a market cap of 6.32M. Regarding current trading prices, ADMP is priced at $0.78, while MVMDF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MVMDF's P/E ratio is -1.79. In terms of profitability, ADMP's ROE is +0.00%, compared to MVMDF's ROE of -0.47%. Regarding short-term risk, ADMP is less volatile compared to MVMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MCUJF has a market cap of 6.26M. Regarding current trading prices, ADMP is priced at $0.78, while MCUJF trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MCUJF's P/E ratio is -8.57. In terms of profitability, ADMP's ROE is +0.00%, compared to MCUJF's ROE of -0.05%. Regarding short-term risk, ADMP is less volatile compared to MCUJF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MMJJF has a market cap of 6.20M. Regarding current trading prices, ADMP is priced at $0.78, while MMJJF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MMJJF's P/E ratio is -1.49. In terms of profitability, ADMP's ROE is +0.00%, compared to MMJJF's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to MMJJF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PCLOF has a market cap of 6.12M. Regarding current trading prices, ADMP is priced at $0.78, while PCLOF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PCLOF's P/E ratio is -0.87. In terms of profitability, ADMP's ROE is +0.00%, compared to PCLOF's ROE of +1.53%. Regarding short-term risk, ADMP is more volatile compared to PCLOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SEHCF has a market cap of 6.03M. Regarding current trading prices, ADMP is priced at $0.78, while SEHCF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SEHCF's P/E ratio is 3.11. In terms of profitability, ADMP's ROE is +0.00%, compared to SEHCF's ROE of -0.71%. Regarding short-term risk, ADMP is less volatile compared to SEHCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BCBCF has a market cap of 5.98M. Regarding current trading prices, ADMP is priced at $0.78, while BCBCF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BCBCF's P/E ratio is -3.62. In terms of profitability, ADMP's ROE is +0.00%, compared to BCBCF's ROE of -4.27%. Regarding short-term risk, ADMP is less volatile compared to BCBCF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VVCIF has a market cap of 5.67M. Regarding current trading prices, ADMP is priced at $0.78, while VVCIF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VVCIF's P/E ratio is -0.15. In terms of profitability, ADMP's ROE is +0.00%, compared to VVCIF's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to VVCIF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, UNVC has a market cap of 5.47M. Regarding current trading prices, ADMP is priced at $0.78, while UNVC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas UNVC's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to UNVC's ROE of +0.08%. Regarding short-term risk, ADMP is less volatile compared to UNVC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CVSI has a market cap of 5.44M. Regarding current trading prices, ADMP is priced at $0.78, while CVSI trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CVSI's P/E ratio is -2.95. In terms of profitability, ADMP's ROE is +0.00%, compared to CVSI's ROE of -1.08%. Regarding short-term risk, ADMP is less volatile compared to CVSI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LIFD has a market cap of 5.34M. Regarding current trading prices, ADMP is priced at $0.78, while LIFD trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LIFD's P/E ratio is -2.77. In terms of profitability, ADMP's ROE is +0.00%, compared to LIFD's ROE of -0.05%. Regarding short-term risk, ADMP is less volatile compared to LIFD. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CLSH has a market cap of 5.25M. Regarding current trading prices, ADMP is priced at $0.78, while CLSH trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CLSH's P/E ratio is 3.19. In terms of profitability, ADMP's ROE is +0.00%, compared to CLSH's ROE of -0.04%. Regarding short-term risk, ADMP is less volatile compared to CLSH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IMCC has a market cap of 5.09M. Regarding current trading prices, ADMP is priced at $0.78, while IMCC trades at $1.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IMCC's P/E ratio is -0.51. In terms of profitability, ADMP's ROE is +0.00%, compared to IMCC's ROE of -1.52%. Regarding short-term risk, ADMP is less volatile compared to IMCC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SNOA has a market cap of 5.09M. Regarding current trading prices, ADMP is priced at $0.78, while SNOA trades at $3.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SNOA's P/E ratio is -1.39. In terms of profitability, ADMP's ROE is +0.00%, compared to SNOA's ROE of -0.70%. Regarding short-term risk, ADMP is less volatile compared to SNOA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TRLFF has a market cap of 5.08M. Regarding current trading prices, ADMP is priced at $0.78, while TRLFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TRLFF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TRLFF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to TRLFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHNC has a market cap of 5.04M. Regarding current trading prices, ADMP is priced at $0.78, while CHNC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHNC's P/E ratio is 0.05. In terms of profitability, ADMP's ROE is +0.00%, compared to CHNC's ROE of +0.37%. Regarding short-term risk, ADMP is less volatile compared to CHNC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACRHF has a market cap of 4.88M. Regarding current trading prices, ADMP is priced at $0.78, while ACRHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACRHF's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ACRHF's ROE of +2.17%. Regarding short-term risk, ADMP is less volatile compared to ACRHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACRDF has a market cap of 4.88M. Regarding current trading prices, ADMP is priced at $0.78, while ACRDF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACRDF's P/E ratio is -0.14. In terms of profitability, ADMP's ROE is +0.00%, compared to ACRDF's ROE of +2.17%. Regarding short-term risk, ADMP is less volatile compared to ACRDF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EOFBF has a market cap of 4.69M. Regarding current trading prices, ADMP is priced at $0.78, while EOFBF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EOFBF's P/E ratio is -0.33. In terms of profitability, ADMP's ROE is +0.00%, compared to EOFBF's ROE of -1.26%. Regarding short-term risk, ADMP is less volatile compared to EOFBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EVOK has a market cap of 4.67M. Regarding current trading prices, ADMP is priced at $0.78, while EVOK trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EVOK's P/E ratio is -1.11. In terms of profitability, ADMP's ROE is +0.00%, compared to EVOK's ROE of -1.22%. Regarding short-term risk, ADMP is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ECGS has a market cap of 4.65M. Regarding current trading prices, ADMP is priced at $0.78, while ECGS trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ECGS's P/E ratio is -2.29. In terms of profitability, ADMP's ROE is +0.00%, compared to ECGS's ROE of +0.18%. Regarding short-term risk, ADMP is more volatile compared to ECGS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VPHIF has a market cap of 4.63M. Regarding current trading prices, ADMP is priced at $0.78, while VPHIF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VPHIF's P/E ratio is -0.18. In terms of profitability, ADMP's ROE is +0.00%, compared to VPHIF's ROE of +0.42%. Regarding short-term risk, ADMP is less volatile compared to VPHIF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SNNVF has a market cap of 4.62M. Regarding current trading prices, ADMP is priced at $0.78, while SNNVF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SNNVF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SNNVF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to SNNVF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SBFMW has a market cap of 4.62M. Regarding current trading prices, ADMP is priced at $0.78, while SBFMW trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SBFMW's P/E ratio is -0.09. In terms of profitability, ADMP's ROE is +0.00%, compared to SBFMW's ROE of -0.21%. Regarding short-term risk, ADMP is more volatile compared to SBFMW. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SBFM has a market cap of 4.54M. Regarding current trading prices, ADMP is priced at $0.78, while SBFM trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SBFM's P/E ratio is -0.17. In terms of profitability, ADMP's ROE is +0.00%, compared to SBFM's ROE of -0.21%. Regarding short-term risk, ADMP is more volatile compared to SBFM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MNK has a market cap of 4.52M. Regarding current trading prices, ADMP is priced at $0.78, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MNK's P/E ratio is -0.44. In terms of profitability, ADMP's ROE is +0.00%, compared to MNK's ROE of -0.74%. Regarding short-term risk, ADMP is less volatile compared to MNK. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BKUH has a market cap of 4.52M. Regarding current trading prices, ADMP is priced at $0.78, while BKUH trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BKUH's P/E ratio is -1.50. In terms of profitability, ADMP's ROE is +0.00%, compared to BKUH's ROE of +0.10%. Regarding short-term risk, ADMP is less volatile compared to BKUH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FLHLF has a market cap of 4.50M. Regarding current trading prices, ADMP is priced at $0.78, while FLHLF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FLHLF's P/E ratio is -1.72. In terms of profitability, ADMP's ROE is +0.00%, compared to FLHLF's ROE of -2.14%. Regarding short-term risk, ADMP is less volatile compared to FLHLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BBRRF has a market cap of 4.47M. Regarding current trading prices, ADMP is priced at $0.78, while BBRRF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BBRRF's P/E ratio is -1.12. In terms of profitability, ADMP's ROE is +0.00%, compared to BBRRF's ROE of -0.72%. Regarding short-term risk, ADMP is less volatile compared to BBRRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IVITF has a market cap of 4.45M. Regarding current trading prices, ADMP is priced at $0.78, while IVITF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IVITF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to IVITF's ROE of -0.32%. Regarding short-term risk, ADMP is less volatile compared to IVITF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GHSI has a market cap of 4.35M. Regarding current trading prices, ADMP is priced at $0.78, while GHSI trades at $3.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GHSI's P/E ratio is -0.78. In terms of profitability, ADMP's ROE is +0.00%, compared to GHSI's ROE of +0.71%. Regarding short-term risk, ADMP is more volatile compared to GHSI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, REZNF has a market cap of 4.25M. Regarding current trading prices, ADMP is priced at $0.78, while REZNF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas REZNF's P/E ratio is -1.51. In terms of profitability, ADMP's ROE is +0.00%, compared to REZNF's ROE of +0.44%. Regarding short-term risk, ADMP is less volatile compared to REZNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BUDZ has a market cap of 4.13M. Regarding current trading prices, ADMP is priced at $0.78, while BUDZ trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BUDZ's P/E ratio is -3.34. In terms of profitability, ADMP's ROE is +0.00%, compared to BUDZ's ROE of +10.52%. Regarding short-term risk, ADMP is less volatile compared to BUDZ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NDVAF has a market cap of 4.11M. Regarding current trading prices, ADMP is priced at $0.78, while NDVAF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NDVAF's P/E ratio is -2.10. In terms of profitability, ADMP's ROE is +0.00%, compared to NDVAF's ROE of +3.13%. Regarding short-term risk, ADMP is less volatile compared to NDVAF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DHBUF has a market cap of 3.98M. Regarding current trading prices, ADMP is priced at $0.78, while DHBUF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DHBUF's P/E ratio is -1.06. In terms of profitability, ADMP's ROE is +0.00%, compared to DHBUF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to DHBUF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, STHZF has a market cap of 3.85M. Regarding current trading prices, ADMP is priced at $0.78, while STHZF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas STHZF's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to STHZF's ROE of +0.22%. Regarding short-term risk, ADMP is less volatile compared to STHZF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHWZ has a market cap of 3.57M. Regarding current trading prices, ADMP is priced at $0.78, while SHWZ trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHWZ's P/E ratio is -0.05. In terms of profitability, ADMP's ROE is +0.00%, compared to SHWZ's ROE of -0.57%. Regarding short-term risk, ADMP is less volatile compared to SHWZ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LUFFF has a market cap of 3.54M. Regarding current trading prices, ADMP is priced at $0.78, while LUFFF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LUFFF's P/E ratio is -0.85. In terms of profitability, ADMP's ROE is +0.00%, compared to LUFFF's ROE of -0.42%. Regarding short-term risk, ADMP is less volatile compared to LUFFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PRFX has a market cap of 3.51M. Regarding current trading prices, ADMP is priced at $0.78, while PRFX trades at $1.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PRFX's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to PRFX's ROE of -7.54%. Regarding short-term risk, ADMP is less volatile compared to PRFX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HERTF has a market cap of 3.47M. Regarding current trading prices, ADMP is priced at $0.78, while HERTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HERTF's P/E ratio is -0.14. In terms of profitability, ADMP's ROE is +0.00%, compared to HERTF's ROE of -0.55%. Regarding short-term risk, ADMP is less volatile compared to HERTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AYURF has a market cap of 3.43M. Regarding current trading prices, ADMP is priced at $0.78, while AYURF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AYURF's P/E ratio is -1.76. In terms of profitability, ADMP's ROE is +0.00%, compared to AYURF's ROE of -1.40%. Regarding short-term risk, ADMP is less volatile compared to AYURF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CANN has a market cap of 3.40M. Regarding current trading prices, ADMP is priced at $0.78, while CANN trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CANN's P/E ratio is -0.62. In terms of profitability, ADMP's ROE is +0.00%, compared to CANN's ROE of +4.15%. Regarding short-term risk, ADMP is less volatile compared to CANN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IXHL has a market cap of 3.13M. Regarding current trading prices, ADMP is priced at $0.78, while IXHL trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IXHL's P/E ratio is -0.08. In terms of profitability, ADMP's ROE is +0.00%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, ADMP is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DLTNF has a market cap of 3.04M. Regarding current trading prices, ADMP is priced at $0.78, while DLTNF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DLTNF's P/E ratio is -0.11. In terms of profitability, ADMP's ROE is +0.00%, compared to DLTNF's ROE of +1.30%. Regarding short-term risk, ADMP is less volatile compared to DLTNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NHPHF has a market cap of 3.03M. Regarding current trading prices, ADMP is priced at $0.78, while NHPHF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NHPHF's P/E ratio is -4.45. In terms of profitability, ADMP's ROE is +0.00%, compared to NHPHF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to NHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNNA has a market cap of 2.95M. Regarding current trading prices, ADMP is priced at $0.78, while CNNA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNNA's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CNNA's ROE of -0.81%. Regarding short-term risk, ADMP is more volatile compared to CNNA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TGIFF has a market cap of 2.94M. Regarding current trading prices, ADMP is priced at $0.78, while TGIFF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TGIFF's P/E ratio is -0.30. In terms of profitability, ADMP's ROE is +0.00%, compared to TGIFF's ROE of +0.24%. Regarding short-term risk, ADMP is less volatile compared to TGIFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CANSF has a market cap of 2.90M. Regarding current trading prices, ADMP is priced at $0.78, while CANSF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CANSF's P/E ratio is -0.50. In terms of profitability, ADMP's ROE is +0.00%, compared to CANSF's ROE of -21.00%. Regarding short-term risk, ADMP is more volatile compared to CANSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IVIXF has a market cap of 2.86M. Regarding current trading prices, ADMP is priced at $0.78, while IVIXF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IVIXF's P/E ratio is -0.53. In terms of profitability, ADMP's ROE is +0.00%, compared to IVIXF's ROE of -0.39%. Regarding short-term risk, ADMP is less volatile compared to IVIXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EEVVF has a market cap of 2.86M. Regarding current trading prices, ADMP is priced at $0.78, while EEVVF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EEVVF's P/E ratio is -0.52. In terms of profitability, ADMP's ROE is +0.00%, compared to EEVVF's ROE of -0.37%. Regarding short-term risk, ADMP is more volatile compared to EEVVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BMCS has a market cap of 2.83M. Regarding current trading prices, ADMP is priced at $0.78, while BMCS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BMCS's P/E ratio is -3.50. In terms of profitability, ADMP's ROE is +0.00%, compared to BMCS's ROE of -0.00%. Regarding short-term risk, ADMP is less volatile compared to BMCS. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TLLTF has a market cap of 2.71M. Regarding current trading prices, ADMP is priced at $0.78, while TLLTF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TLLTF's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to TLLTF's ROE of -10.80%. Regarding short-term risk, ADMP is less volatile compared to TLLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ELLXF has a market cap of 2.70M. Regarding current trading prices, ADMP is priced at $0.78, while ELLXF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ELLXF's P/E ratio is -0.61. In terms of profitability, ADMP's ROE is +0.00%, compared to ELLXF's ROE of -0.79%. Regarding short-term risk, ADMP is less volatile compared to ELLXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AKAN has a market cap of 2.66M. Regarding current trading prices, ADMP is priced at $0.78, while AKAN trades at $1.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AKAN's P/E ratio is -0.37. In terms of profitability, ADMP's ROE is +0.00%, compared to AKAN's ROE of -78.46%. Regarding short-term risk, ADMP is more volatile compared to AKAN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EDXC has a market cap of 2.66M. Regarding current trading prices, ADMP is priced at $0.78, while EDXC trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EDXC's P/E ratio is 0.53. In terms of profitability, ADMP's ROE is +0.00%, compared to EDXC's ROE of +0.04%. Regarding short-term risk, ADMP is less volatile compared to EDXC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, STEK has a market cap of 2.60M. Regarding current trading prices, ADMP is priced at $0.78, while STEK trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas STEK's P/E ratio is -0.39. In terms of profitability, ADMP's ROE is +0.00%, compared to STEK's ROE of +1.38%. Regarding short-term risk, ADMP is less volatile compared to STEK. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CANB has a market cap of 2.59M. Regarding current trading prices, ADMP is priced at $0.78, while CANB trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CANB's P/E ratio is 0.38. In terms of profitability, ADMP's ROE is +0.00%, compared to CANB's ROE of +2.20%. Regarding short-term risk, ADMP is more volatile compared to CANB. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TWSI has a market cap of 2.58M. Regarding current trading prices, ADMP is priced at $0.78, while TWSI trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TWSI's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to TWSI's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to TWSI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PLXP has a market cap of 2.53M. Regarding current trading prices, ADMP is priced at $0.78, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PLXP's P/E ratio is -0.22. In terms of profitability, ADMP's ROE is +0.00%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, ADMP is less volatile compared to PLXP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FFNTF has a market cap of 2.51M. Regarding current trading prices, ADMP is priced at $0.78, while FFNTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FFNTF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to FFNTF's ROE of +0.75%. Regarding short-term risk, ADMP is less volatile compared to FFNTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CIMVF has a market cap of 2.51M. Regarding current trading prices, ADMP is priced at $0.78, while CIMVF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CIMVF's P/E ratio is -0.11. In terms of profitability, ADMP's ROE is +0.00%, compared to CIMVF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to CIMVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NOBDF has a market cap of 2.42M. Regarding current trading prices, ADMP is priced at $0.78, while NOBDF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NOBDF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, ADMP is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, XBRAF has a market cap of 2.40M. Regarding current trading prices, ADMP is priced at $0.78, while XBRAF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas XBRAF's P/E ratio is -1.59. In terms of profitability, ADMP's ROE is +0.00%, compared to XBRAF's ROE of -20.92%. Regarding short-term risk, ADMP is more volatile compared to XBRAF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GENPF has a market cap of 2.37M. Regarding current trading prices, ADMP is priced at $0.78, while GENPF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GENPF's P/E ratio is -0.80. In terms of profitability, ADMP's ROE is +0.00%, compared to GENPF's ROE of +0.09%. Regarding short-term risk, ADMP is less volatile compared to GENPF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ATNX has a market cap of 2.33M. Regarding current trading prices, ADMP is priced at $0.78, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ATNX's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, ADMP is more volatile compared to ATNX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MNFSF has a market cap of 2.26M. Regarding current trading prices, ADMP is priced at $0.78, while MNFSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MNFSF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, ADMP is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OWPC has a market cap of 2.22M. Regarding current trading prices, ADMP is priced at $0.78, while OWPC trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OWPC's P/E ratio is -0.35. In terms of profitability, ADMP's ROE is +0.00%, compared to OWPC's ROE of +0.99%. Regarding short-term risk, ADMP is less volatile compared to OWPC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHPH has a market cap of 2.21M. Regarding current trading prices, ADMP is priced at $0.78, while SHPH trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHPH's P/E ratio is -0.16. In terms of profitability, ADMP's ROE is +0.00%, compared to SHPH's ROE of -12.37%. Regarding short-term risk, ADMP is less volatile compared to SHPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NRPR has a market cap of 2.21M. Regarding current trading prices, ADMP is priced at $0.78, while NRPR trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NRPR's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to NRPR's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to NRPR. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IGEX has a market cap of 2.20M. Regarding current trading prices, ADMP is priced at $0.78, while IGEX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IGEX's P/E ratio is -0.05. In terms of profitability, ADMP's ROE is +0.00%, compared to IGEX's ROE of +1.13%. Regarding short-term risk, ADMP is less volatile compared to IGEX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CPMD has a market cap of 2.19M. Regarding current trading prices, ADMP is priced at $0.78, while CPMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CPMD's P/E ratio is -0.16. In terms of profitability, ADMP's ROE is +0.00%, compared to CPMD's ROE of +0.52%. Regarding short-term risk, ADMP is more volatile compared to CPMD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBDNF has a market cap of 2.07M. Regarding current trading prices, ADMP is priced at $0.78, while CBDNF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBDNF's P/E ratio is -0.35. In terms of profitability, ADMP's ROE is +0.00%, compared to CBDNF's ROE of +1.05%. Regarding short-term risk, ADMP is less volatile compared to CBDNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RCMW has a market cap of 2.03M. Regarding current trading prices, ADMP is priced at $0.78, while RCMW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RCMW's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to RCMW's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to RCMW. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ISCNF has a market cap of 1.99M. Regarding current trading prices, ADMP is priced at $0.78, while ISCNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ISCNF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to ISCNF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to ISCNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ALID has a market cap of 1.96M. Regarding current trading prices, ADMP is priced at $0.78, while ALID trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ALID's P/E ratio is -0.43. In terms of profitability, ADMP's ROE is +0.00%, compared to ALID's ROE of +2.61%. Regarding short-term risk, ADMP is more volatile compared to ALID. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ANTCF has a market cap of 1.93M. Regarding current trading prices, ADMP is priced at $0.78, while ANTCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ANTCF's P/E ratio is -0.40. In terms of profitability, ADMP's ROE is +0.00%, compared to ANTCF's ROE of +1.59%. Regarding short-term risk, ADMP is more volatile compared to ANTCF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EVIO has a market cap of 1.92M. Regarding current trading prices, ADMP is priced at $0.78, while EVIO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EVIO's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to EVIO's ROE of -0.00%. Regarding short-term risk, ADMP is less volatile compared to EVIO. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BHHKF has a market cap of 1.92M. Regarding current trading prices, ADMP is priced at $0.78, while BHHKF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BHHKF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, ADMP is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OVATF has a market cap of 1.82M. Regarding current trading prices, ADMP is priced at $0.78, while OVATF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OVATF's P/E ratio is -4.82. In terms of profitability, ADMP's ROE is +0.00%, compared to OVATF's ROE of +0.76%. Regarding short-term risk, ADMP is less volatile compared to OVATF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHOOF has a market cap of 1.78M. Regarding current trading prices, ADMP is priced at $0.78, while CHOOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHOOF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CHOOF's ROE of +4.09%. Regarding short-term risk, ADMP is less volatile compared to CHOOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FLOOF has a market cap of 1.75M. Regarding current trading prices, ADMP is priced at $0.78, while FLOOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FLOOF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to FLOOF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to FLOOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OMID has a market cap of 1.74M. Regarding current trading prices, ADMP is priced at $0.78, while OMID trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OMID's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to OMID's ROE of -1.36%. Regarding short-term risk, ADMP is less volatile compared to OMID. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SILFF has a market cap of 1.73M. Regarding current trading prices, ADMP is priced at $0.78, while SILFF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SILFF's P/E ratio is 0.14. In terms of profitability, ADMP's ROE is +0.00%, compared to SILFF's ROE of +2.05%. Regarding short-term risk, ADMP is more volatile compared to SILFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PARNF has a market cap of 1.68M. Regarding current trading prices, ADMP is priced at $0.78, while PARNF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PARNF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to PARNF's ROE of +0.04%. Regarding short-term risk, ADMP is less volatile compared to PARNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACNNF has a market cap of 1.67M. Regarding current trading prices, ADMP is priced at $0.78, while ACNNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACNNF's P/E ratio is -0.13. In terms of profitability, ADMP's ROE is +0.00%, compared to ACNNF's ROE of -0.89%. Regarding short-term risk, ADMP is more volatile compared to ACNNF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NGMC has a market cap of 1.54M. Regarding current trading prices, ADMP is priced at $0.78, while NGMC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NGMC's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to NGMC's ROE of -0.98%. Regarding short-term risk, ADMP is less volatile compared to NGMC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NNRX has a market cap of 1.53M. Regarding current trading prices, ADMP is priced at $0.78, while NNRX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NNRX's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to NNRX's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to NNRX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KAYS has a market cap of 1.50M. Regarding current trading prices, ADMP is priced at $0.78, while KAYS trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KAYS's P/E ratio is -0.52. In terms of profitability, ADMP's ROE is +0.00%, compared to KAYS's ROE of +0.20%. Regarding short-term risk, ADMP is more volatile compared to KAYS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BMMJ has a market cap of 1.48M. Regarding current trading prices, ADMP is priced at $0.78, while BMMJ trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BMMJ's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to BMMJ's ROE of +0.43%. Regarding short-term risk, ADMP is less volatile compared to BMMJ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PROCW has a market cap of 1.46M. Regarding current trading prices, ADMP is priced at $0.78, while PROCW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PROCW's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, ADMP is less volatile compared to PROCW. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PCYN has a market cap of 1.46M. Regarding current trading prices, ADMP is priced at $0.78, while PCYN trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PCYN's P/E ratio is -4.50. In terms of profitability, ADMP's ROE is +0.00%, compared to PCYN's ROE of -0.13%. Regarding short-term risk, ADMP is more volatile compared to PCYN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ABTI has a market cap of 1.46M. Regarding current trading prices, ADMP is priced at $0.78, while ABTI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ABTI's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, ADMP is less volatile compared to ABTI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RPNRF has a market cap of 1.45M. Regarding current trading prices, ADMP is priced at $0.78, while RPNRF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RPNRF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to RPNRF's ROE of -13.98%. Regarding short-term risk, ADMP is more volatile compared to RPNRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EXMT has a market cap of 1.44M. Regarding current trading prices, ADMP is priced at $0.78, while EXMT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EXMT's P/E ratio is -0.12. In terms of profitability, ADMP's ROE is +0.00%, compared to EXMT's ROE of +0.28%. Regarding short-term risk, ADMP is less volatile compared to EXMT. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PBFFF has a market cap of 1.34M. Regarding current trading prices, ADMP is priced at $0.78, while PBFFF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PBFFF's P/E ratio is -0.16. In terms of profitability, ADMP's ROE is +0.00%, compared to PBFFF's ROE of +1.54%. Regarding short-term risk, ADMP is less volatile compared to PBFFF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CTTH has a market cap of 1.33M. Regarding current trading prices, ADMP is priced at $0.78, while CTTH trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CTTH's P/E ratio is -6.25. In terms of profitability, ADMP's ROE is +0.00%, compared to CTTH's ROE of -3.49%. Regarding short-term risk, ADMP is more volatile compared to CTTH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACUR has a market cap of 1.32M. Regarding current trading prices, ADMP is priced at $0.78, while ACUR trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACUR's P/E ratio is -1.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ACUR's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to ACUR. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DKSC has a market cap of 1.31M. Regarding current trading prices, ADMP is priced at $0.78, while DKSC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DKSC's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to DKSC's ROE of -1.13%. Regarding short-term risk, ADMP is more volatile compared to DKSC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NUNZ has a market cap of 1.30M. Regarding current trading prices, ADMP is priced at $0.78, while NUNZ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NUNZ's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to NUNZ's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to NUNZ. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, STMH has a market cap of 1.25M. Regarding current trading prices, ADMP is priced at $0.78, while STMH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas STMH's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to STMH's ROE of -2.75%. Regarding short-term risk, ADMP is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ETRGF has a market cap of 1.23M. Regarding current trading prices, ADMP is priced at $0.78, while ETRGF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ETRGF's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to ETRGF's ROE of +0.26%. Regarding short-term risk, ADMP is more volatile compared to ETRGF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OASMY has a market cap of 1.20M. Regarding current trading prices, ADMP is priced at $0.78, while OASMY trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OASMY's P/E ratio is -1.00. In terms of profitability, ADMP's ROE is +0.00%, compared to OASMY's ROE of -0.84%. Regarding short-term risk, ADMP is less volatile compared to OASMY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BINP has a market cap of 1.17M. Regarding current trading prices, ADMP is priced at $0.78, while BINP trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BINP's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to BINP's ROE of -0.20%. Regarding short-term risk, ADMP is less volatile compared to BINP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GXXY has a market cap of 1.15M. Regarding current trading prices, ADMP is priced at $0.78, while GXXY trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GXXY's P/E ratio is -2.00. In terms of profitability, ADMP's ROE is +0.00%, compared to GXXY's ROE of +3.12%. Regarding short-term risk, ADMP is less volatile compared to GXXY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MJNA has a market cap of 1.14M. Regarding current trading prices, ADMP is priced at $0.78, while MJNA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MJNA's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to MJNA's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to MJNA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LVVV has a market cap of 1.06M. Regarding current trading prices, ADMP is priced at $0.78, while LVVV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LVVV's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to LVVV's ROE of +0.11%. Regarding short-term risk, ADMP is less volatile compared to LVVV. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, UPC has a market cap of 1.06M. Regarding current trading prices, ADMP is priced at $0.78, while UPC trades at $4.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas UPC's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to UPC's ROE of -0.14%. Regarding short-term risk, ADMP is less volatile compared to UPC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBDY has a market cap of 1.05M. Regarding current trading prices, ADMP is priced at $0.78, while CBDY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBDY's P/E ratio is -0.17. In terms of profitability, ADMP's ROE is +0.00%, compared to CBDY's ROE of -0.02%. Regarding short-term risk, ADMP is more volatile compared to CBDY. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HPST has a market cap of 1.02M. Regarding current trading prices, ADMP is priced at $0.78, while HPST trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HPST's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HPST's ROE of +0.94%. Regarding short-term risk, ADMP is less volatile compared to HPST. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PLSH has a market cap of 1.01M. Regarding current trading prices, ADMP is priced at $0.78, while PLSH trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PLSH's P/E ratio is -0.14. In terms of profitability, ADMP's ROE is +0.00%, compared to PLSH's ROE of +0.06%. Regarding short-term risk, ADMP is less volatile compared to PLSH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HBRM has a market cap of 962952.00. Regarding current trading prices, ADMP is priced at $0.78, while HBRM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HBRM's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HBRM's ROE of +0.08%. Regarding short-term risk, ADMP is less volatile compared to HBRM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MCIC has a market cap of 918673.00. Regarding current trading prices, ADMP is priced at $0.78, while MCIC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MCIC's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to MCIC's ROE of +0.18%. Regarding short-term risk, ADMP is less volatile compared to MCIC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LSDI has a market cap of 906910.00. Regarding current trading prices, ADMP is priced at $0.78, while LSDI trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LSDI's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to LSDI's ROE of -2.97%. Regarding short-term risk, ADMP is less volatile compared to LSDI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CYTHW has a market cap of 899367.00. Regarding current trading prices, ADMP is priced at $0.78, while CYTHW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CYTHW's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CYTHW's ROE of +7.50%. Regarding short-term risk, ADMP is more volatile compared to CYTHW. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PRXTF has a market cap of 885394.00. Regarding current trading prices, ADMP is priced at $0.78, while PRXTF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PRXTF's P/E ratio is -0.27. In terms of profitability, ADMP's ROE is +0.00%, compared to PRXTF's ROE of -1.18%. Regarding short-term risk, ADMP is less volatile compared to PRXTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HEMP has a market cap of 882950.00. Regarding current trading prices, ADMP is priced at $0.78, while HEMP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HEMP's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to HEMP's ROE of -0.39%. Regarding short-term risk, ADMP is less volatile compared to HEMP. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, WOWU has a market cap of 880642.00. Regarding current trading prices, ADMP is priced at $0.78, while WOWU trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas WOWU's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to WOWU's ROE of +1.58%. Regarding short-term risk, ADMP is less volatile compared to WOWU. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CATV has a market cap of 865619.00. Regarding current trading prices, ADMP is priced at $0.78, while CATV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CATV's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CATV's ROE of -0.01%. Regarding short-term risk, ADMP is less volatile compared to CATV. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NEPT has a market cap of 857046.00. Regarding current trading prices, ADMP is priced at $0.78, while NEPT trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NEPT's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to NEPT's ROE of +0.78%. Regarding short-term risk, ADMP is less volatile compared to NEPT. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CVGRF has a market cap of 836148.00. Regarding current trading prices, ADMP is priced at $0.78, while CVGRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CVGRF's P/E ratio is -0.30. In terms of profitability, ADMP's ROE is +0.00%, compared to CVGRF's ROE of +0.52%. Regarding short-term risk, ADMP is more volatile compared to CVGRF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, JWCAF has a market cap of 832171.00. Regarding current trading prices, ADMP is priced at $0.78, while JWCAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas JWCAF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to JWCAF's ROE of -0.45%. Regarding short-term risk, ADMP is less volatile compared to JWCAF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ACOR has a market cap of 821028.00. Regarding current trading prices, ADMP is priced at $0.78, while ACOR trades at $0.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ACOR's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ACOR's ROE of +4.86%. Regarding short-term risk, ADMP is less volatile compared to ACOR. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SHMN has a market cap of 787790.00. Regarding current trading prices, ADMP is priced at $0.78, while SHMN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SHMN's P/E ratio is -0.25. In terms of profitability, ADMP's ROE is +0.00%, compared to SHMN's ROE of +4.80%. Regarding short-term risk, ADMP is less volatile compared to SHMN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ERBB has a market cap of 777343.00. Regarding current trading prices, ADMP is priced at $0.78, while ERBB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ERBB's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to ERBB's ROE of +0.31%. Regarding short-term risk, ADMP is less volatile compared to ERBB. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FAGI has a market cap of 770592.00. Regarding current trading prices, ADMP is priced at $0.78, while FAGI trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FAGI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to FAGI's ROE of -0.67%. Regarding short-term risk, ADMP is more volatile compared to FAGI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NBGV has a market cap of 769176.00. Regarding current trading prices, ADMP is priced at $0.78, while NBGV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NBGV's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to NBGV's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to NBGV. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SPLIF has a market cap of 767564.00. Regarding current trading prices, ADMP is priced at $0.78, while SPLIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SPLIF's P/E ratio is -0.20. In terms of profitability, ADMP's ROE is +0.00%, compared to SPLIF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to SPLIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NPHC has a market cap of 759685.00. Regarding current trading prices, ADMP is priced at $0.78, while NPHC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NPHC's P/E ratio is 0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to NPHC's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to NPHC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBDL has a market cap of 750788.00. Regarding current trading prices, ADMP is priced at $0.78, while CBDL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBDL's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to CBDL's ROE of -2.13%. Regarding short-term risk, ADMP is less volatile compared to CBDL. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TRCNF has a market cap of 739106.00. Regarding current trading prices, ADMP is priced at $0.78, while TRCNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TRCNF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TRCNF's ROE of -1.92%. Regarding short-term risk, ADMP is less volatile compared to TRCNF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, YCBD has a market cap of 732751.00. Regarding current trading prices, ADMP is priced at $0.78, while YCBD trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas YCBD's P/E ratio is -0.09. In terms of profitability, ADMP's ROE is +0.00%, compared to YCBD's ROE of -1.50%. Regarding short-term risk, ADMP is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LMLLF has a market cap of 725791.00. Regarding current trading prices, ADMP is priced at $0.78, while LMLLF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LMLLF's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to LMLLF's ROE of +8.87%. Regarding short-term risk, ADMP is less volatile compared to LMLLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BSPK has a market cap of 717151.00. Regarding current trading prices, ADMP is priced at $0.78, while BSPK trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BSPK's P/E ratio is -0.64. In terms of profitability, ADMP's ROE is +0.00%, compared to BSPK's ROE of +13.75%. Regarding short-term risk, ADMP is more volatile compared to BSPK. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, NXEN has a market cap of 707722.00. Regarding current trading prices, ADMP is priced at $0.78, while NXEN trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas NXEN's P/E ratio is -1.00. In terms of profitability, ADMP's ROE is +0.00%, compared to NXEN's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to NXEN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PHBI has a market cap of 663646.00. Regarding current trading prices, ADMP is priced at $0.78, while PHBI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PHBI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to PHBI's ROE of +0.09%. Regarding short-term risk, ADMP is less volatile compared to PHBI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VDQSF has a market cap of 630081.00. Regarding current trading prices, ADMP is priced at $0.78, while VDQSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VDQSF's P/E ratio is -0.12. In terms of profitability, ADMP's ROE is +0.00%, compared to VDQSF's ROE of +0.57%. Regarding short-term risk, ADMP is less volatile compared to VDQSF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CHMJF has a market cap of 625949.00. Regarding current trading prices, ADMP is priced at $0.78, while CHMJF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CHMJF's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to CHMJF's ROE of +2.05%. Regarding short-term risk, ADMP is less volatile compared to CHMJF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IONKF has a market cap of 584465.00. Regarding current trading prices, ADMP is priced at $0.78, while IONKF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IONKF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to IONKF's ROE of -3.92%. Regarding short-term risk, ADMP is less volatile compared to IONKF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SLGWF has a market cap of 579129.00. Regarding current trading prices, ADMP is priced at $0.78, while SLGWF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SLGWF's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to SLGWF's ROE of +4.06%. Regarding short-term risk, ADMP is less volatile compared to SLGWF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GPFT has a market cap of 573922.00. Regarding current trading prices, ADMP is priced at $0.78, while GPFT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GPFT's P/E ratio is -0.08. In terms of profitability, ADMP's ROE is +0.00%, compared to GPFT's ROE of +0.16%. Regarding short-term risk, ADMP is less volatile compared to GPFT. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SNNC has a market cap of 555750.00. Regarding current trading prices, ADMP is priced at $0.78, while SNNC trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SNNC's P/E ratio is -0.45. In terms of profitability, ADMP's ROE is +0.00%, compared to SNNC's ROE of +1.29%. Regarding short-term risk, ADMP is less volatile compared to SNNC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TMSH has a market cap of 543261.00. Regarding current trading prices, ADMP is priced at $0.78, while TMSH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TMSH's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TMSH's ROE of -0.13%. Regarding short-term risk, ADMP is more volatile compared to TMSH. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VRTHF has a market cap of 535449.00. Regarding current trading prices, ADMP is priced at $0.78, while VRTHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VRTHF's P/E ratio is -0.05. In terms of profitability, ADMP's ROE is +0.00%, compared to VRTHF's ROE of +1.22%. Regarding short-term risk, ADMP is less volatile compared to VRTHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MGWFF has a market cap of 531456.00. Regarding current trading prices, ADMP is priced at $0.78, while MGWFF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MGWFF's P/E ratio is -1.37. In terms of profitability, ADMP's ROE is +0.00%, compared to MGWFF's ROE of +0.03%. Regarding short-term risk, ADMP is more volatile compared to MGWFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MPXOF has a market cap of 530867.00. Regarding current trading prices, ADMP is priced at $0.78, while MPXOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MPXOF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to MPXOF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to MPXOF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AQSZF has a market cap of 530536.00. Regarding current trading prices, ADMP is priced at $0.78, while AQSZF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AQSZF's P/E ratio is -0.40. In terms of profitability, ADMP's ROE is +0.00%, compared to AQSZF's ROE of +0.51%. Regarding short-term risk, ADMP is more volatile compared to AQSZF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CSUI has a market cap of 530107.00. Regarding current trading prices, ADMP is priced at $0.78, while CSUI trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CSUI's P/E ratio is -0.19. In terms of profitability, ADMP's ROE is +0.00%, compared to CSUI's ROE of +0.90%. Regarding short-term risk, ADMP is more volatile compared to CSUI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SBUDF has a market cap of 529966.00. Regarding current trading prices, ADMP is priced at $0.78, while SBUDF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SBUDF's P/E ratio is -0.06. In terms of profitability, ADMP's ROE is +0.00%, compared to SBUDF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to SBUDF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AOXG has a market cap of 502979.00. Regarding current trading prices, ADMP is priced at $0.78, while AOXG trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AOXG's P/E ratio is -0.66. In terms of profitability, ADMP's ROE is +0.00%, compared to AOXG's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to AOXG. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, STSN has a market cap of 502404.00. Regarding current trading prices, ADMP is priced at $0.78, while STSN trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas STSN's P/E ratio is -0.57. In terms of profitability, ADMP's ROE is +0.00%, compared to STSN's ROE of +0.94%. Regarding short-term risk, ADMP is more volatile compared to STSN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, YCBD-PA has a market cap of 485977.00. Regarding current trading prices, ADMP is priced at $0.78, while YCBD-PA trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas YCBD-PA's P/E ratio is -1.41. In terms of profitability, ADMP's ROE is +0.00%, compared to YCBD-PA's ROE of -1.50%. Regarding short-term risk, ADMP is more volatile compared to YCBD-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RVVQF has a market cap of 482110.00. Regarding current trading prices, ADMP is priced at $0.78, while RVVQF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RVVQF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to RVVQF's ROE of -2.03%. Regarding short-term risk, ADMP is less volatile compared to RVVQF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LAXAF has a market cap of 475341.00. Regarding current trading prices, ADMP is priced at $0.78, while LAXAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LAXAF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to LAXAF's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to LAXAF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LTTSF has a market cap of 458846.00. Regarding current trading prices, ADMP is priced at $0.78, while LTTSF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LTTSF's P/E ratio is -0.51. In terms of profitability, ADMP's ROE is +0.00%, compared to LTTSF's ROE of -0.10%. Regarding short-term risk, ADMP is more volatile compared to LTTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FTEG has a market cap of 440151.00. Regarding current trading prices, ADMP is priced at $0.78, while FTEG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FTEG's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to FTEG's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to FTEG. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MSMY has a market cap of 424754.00. Regarding current trading prices, ADMP is priced at $0.78, while MSMY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MSMY's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to MSMY's ROE of +0.15%. Regarding short-term risk, ADMP is less volatile compared to MSMY. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BIOIF has a market cap of 406063.00. Regarding current trading prices, ADMP is priced at $0.78, while BIOIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, ADMP is more volatile compared to BIOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TCNAF has a market cap of 396810.00. Regarding current trading prices, ADMP is priced at $0.78, while TCNAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TCNAF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to TCNAF's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to TCNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LVVEF has a market cap of 381098.00. Regarding current trading prices, ADMP is priced at $0.78, while LVVEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LVVEF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to LVVEF's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to LVVEF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CSTF has a market cap of 377345.00. Regarding current trading prices, ADMP is priced at $0.78, while CSTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CSTF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CSTF's ROE of +0.08%. Regarding short-term risk, ADMP is more volatile compared to CSTF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GCAN has a market cap of 372355.00. Regarding current trading prices, ADMP is priced at $0.78, while GCAN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GCAN's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GCAN's ROE of +0.23%. Regarding short-term risk, ADMP is less volatile compared to GCAN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LOBEF has a market cap of 366478.00. Regarding current trading prices, ADMP is priced at $0.78, while LOBEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LOBEF's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to LOBEF's ROE of +2.09%. Regarding short-term risk, ADMP is less volatile compared to LOBEF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PLSI has a market cap of 365910.00. Regarding current trading prices, ADMP is priced at $0.78, while PLSI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PLSI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to PLSI's ROE of -0.71%. Regarding short-term risk, ADMP is more volatile compared to PLSI. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AGFAF has a market cap of 341857.00. Regarding current trading prices, ADMP is priced at $0.78, while AGFAF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AGFAF's P/E ratio is 0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to AGFAF's ROE of +0.84%. Regarding short-term risk, ADMP is less volatile compared to AGFAF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AXRX has a market cap of 338820.00. Regarding current trading prices, ADMP is priced at $0.78, while AXRX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AXRX's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to AXRX's ROE of +0.01%. Regarding short-term risk, ADMP is more volatile compared to AXRX. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNTRF has a market cap of 324232.00. Regarding current trading prices, ADMP is priced at $0.78, while CNTRF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNTRF's P/E ratio is -0.40. In terms of profitability, ADMP's ROE is +0.00%, compared to CNTRF's ROE of +0.29%. Regarding short-term risk, ADMP is less volatile compared to CNTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INQD has a market cap of 320570.00. Regarding current trading prices, ADMP is priced at $0.78, while INQD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INQD's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to INQD's ROE of +11.02%. Regarding short-term risk, ADMP is more volatile compared to INQD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PHCG has a market cap of 318846.00. Regarding current trading prices, ADMP is priced at $0.78, while PHCG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PHCG's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to PHCG's ROE of +0.09%. Regarding short-term risk, ADMP is more volatile compared to PHCG. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, AREVF has a market cap of 317624.00. Regarding current trading prices, ADMP is priced at $0.78, while AREVF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas AREVF's P/E ratio is -1.00. In terms of profitability, ADMP's ROE is +0.00%, compared to AREVF's ROE of +2.76%. Regarding short-term risk, ADMP is more volatile compared to AREVF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRPS has a market cap of 313420.00. Regarding current trading prices, ADMP is priced at $0.78, while GRPS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRPS's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GRPS's ROE of +2.18%. Regarding short-term risk, ADMP is more volatile compared to GRPS. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VIBEF has a market cap of 302316.00. Regarding current trading prices, ADMP is priced at $0.78, while VIBEF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VIBEF's P/E ratio is -0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to VIBEF's ROE of -18.84%. Regarding short-term risk, ADMP is more volatile compared to VIBEF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VEGGD has a market cap of 295925.00. Regarding current trading prices, ADMP is priced at $0.78, while VEGGD trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VEGGD's P/E ratio is -0.14. In terms of profitability, ADMP's ROE is +0.00%, compared to VEGGD's ROE of +0.88%. Regarding short-term risk, ADMP is more volatile compared to VEGGD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HMPQ has a market cap of 291753.00. Regarding current trading prices, ADMP is priced at $0.78, while HMPQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HMPQ's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HMPQ's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to HMPQ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GBHPF has a market cap of 291498.00. Regarding current trading prices, ADMP is priced at $0.78, while GBHPF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GBHPF's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to GBHPF's ROE of +0.11%. Regarding short-term risk, ADMP is more volatile compared to GBHPF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FWDG has a market cap of 263644.00. Regarding current trading prices, ADMP is priced at $0.78, while FWDG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FWDG's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to FWDG's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to FWDG. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRCU has a market cap of 261317.00. Regarding current trading prices, ADMP is priced at $0.78, while GRCU trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRCU's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GRCU's ROE of -0.33%. Regarding short-term risk, ADMP is less volatile compared to GRCU. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PTPI has a market cap of 257076.00. Regarding current trading prices, ADMP is priced at $0.78, while PTPI trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PTPI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to PTPI's ROE of -5.52%. Regarding short-term risk, ADMP is less volatile compared to PTPI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SKYI has a market cap of 251953.00. Regarding current trading prices, ADMP is priced at $0.78, while SKYI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SKYI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SKYI's ROE of +0.53%. Regarding short-term risk, ADMP is less volatile compared to SKYI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GSAC has a market cap of 247192.00. Regarding current trading prices, ADMP is priced at $0.78, while GSAC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GSAC's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GSAC's ROE of +0.19%. Regarding short-term risk, ADMP is more volatile compared to GSAC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CANQF has a market cap of 241632.00. Regarding current trading prices, ADMP is priced at $0.78, while CANQF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CANQF's P/E ratio is -1.20. In terms of profitability, ADMP's ROE is +0.00%, compared to CANQF's ROE of +1.39%. Regarding short-term risk, ADMP is less volatile compared to CANQF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, RMRK has a market cap of 234228.00. Regarding current trading prices, ADMP is priced at $0.78, while RMRK trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas RMRK's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to RMRK's ROE of +0.07%. Regarding short-term risk, ADMP is more volatile compared to RMRK. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VCBDQ has a market cap of 227440.00. Regarding current trading prices, ADMP is priced at $0.78, while VCBDQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VCBDQ's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to VCBDQ's ROE of +17.00%. Regarding short-term risk, ADMP is less volatile compared to VCBDQ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SFLM has a market cap of 223871.00. Regarding current trading prices, ADMP is priced at $0.78, while SFLM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SFLM's P/E ratio is -0.05. In terms of profitability, ADMP's ROE is +0.00%, compared to SFLM's ROE of +0.01%. Regarding short-term risk, ADMP is more volatile compared to SFLM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, XTXXF has a market cap of 211568.00. Regarding current trading prices, ADMP is priced at $0.78, while XTXXF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas XTXXF's P/E ratio is -0.11. In terms of profitability, ADMP's ROE is +0.00%, compared to XTXXF's ROE of -0.19%. Regarding short-term risk, ADMP is less volatile compared to XTXXF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BNOWD has a market cap of 209771.00. Regarding current trading prices, ADMP is priced at $0.78, while BNOWD trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BNOWD's P/E ratio is 0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to BNOWD's ROE of N/A. Regarding short-term risk, ADMP is more volatile compared to BNOWD. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CAAOF has a market cap of 208474.00. Regarding current trading prices, ADMP is priced at $0.78, while CAAOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CAAOF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CAAOF's ROE of -2.10%. Regarding short-term risk, ADMP is less volatile compared to CAAOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MCOA has a market cap of 198048.00. Regarding current trading prices, ADMP is priced at $0.78, while MCOA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MCOA's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to MCOA's ROE of +3.29%. Regarding short-term risk, ADMP is less volatile compared to MCOA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GRVE has a market cap of 190858.00. Regarding current trading prices, ADMP is priced at $0.78, while GRVE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GRVE's P/E ratio is -0.32. In terms of profitability, ADMP's ROE is +0.00%, compared to GRVE's ROE of +0.25%. Regarding short-term risk, ADMP is more volatile compared to GRVE. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LRSV has a market cap of 188821.00. Regarding current trading prices, ADMP is priced at $0.78, while LRSV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LRSV's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to LRSV's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to LRSV. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, LOWLF has a market cap of 181497.00. Regarding current trading prices, ADMP is priced at $0.78, while LOWLF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas LOWLF's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to LOWLF's ROE of -2.59%. Regarding short-term risk, ADMP is less volatile compared to LOWLF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HPMM has a market cap of 174630.00. Regarding current trading prices, ADMP is priced at $0.78, while HPMM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HPMM's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HPMM's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to HPMM. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PVTTF has a market cap of 172430.00. Regarding current trading prices, ADMP is priced at $0.78, while PVTTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PVTTF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to PVTTF's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to PVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MYCOF has a market cap of 168648.00. Regarding current trading prices, ADMP is priced at $0.78, while MYCOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MYCOF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to MYCOF's ROE of +1.01%. Regarding short-term risk, ADMP is less volatile compared to MYCOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EDNEF has a market cap of 150895.00. Regarding current trading prices, ADMP is priced at $0.78, while EDNEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EDNEF's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to EDNEF's ROE of -2.87%. Regarding short-term risk, ADMP is more volatile compared to EDNEF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CTABF has a market cap of 147018.00. Regarding current trading prices, ADMP is priced at $0.78, while CTABF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CTABF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CTABF's ROE of -3.77%. Regarding short-term risk, ADMP is less volatile compared to CTABF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DVLP has a market cap of 141349.00. Regarding current trading prices, ADMP is priced at $0.78, while DVLP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DVLP's P/E ratio is -0.10. In terms of profitability, ADMP's ROE is +0.00%, compared to DVLP's ROE of -2.68%. Regarding short-term risk, ADMP is more volatile compared to DVLP. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, MMNFF has a market cap of 138320.00. Regarding current trading prices, ADMP is priced at $0.78, while MMNFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas MMNFF's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to MMNFF's ROE of -0.96%. Regarding short-term risk, ADMP is more volatile compared to MMNFF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, USMJ has a market cap of 137858.00. Regarding current trading prices, ADMP is priced at $0.78, while USMJ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas USMJ's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to USMJ's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to USMJ. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, WRHLF has a market cap of 119920.00. Regarding current trading prices, ADMP is priced at $0.78, while WRHLF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas WRHLF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to WRHLF's ROE of -1.29%. Regarding short-term risk, ADMP is more volatile compared to WRHLF. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SYUP has a market cap of 108025.00. Regarding current trading prices, ADMP is priced at $0.78, while SYUP trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SYUP's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SYUP's ROE of +0.86%. Regarding short-term risk, ADMP is more volatile compared to SYUP. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, BBBT has a market cap of 98405.00. Regarding current trading prices, ADMP is priced at $0.78, while BBBT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas BBBT's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to BBBT's ROE of -165.55%. Regarding short-term risk, ADMP is more volatile compared to BBBT. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SLNX has a market cap of 95200.00. Regarding current trading prices, ADMP is priced at $0.78, while SLNX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SLNX's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SLNX's ROE of +1.18%. Regarding short-term risk, ADMP is less volatile compared to SLNX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CANL has a market cap of 93317.00. Regarding current trading prices, ADMP is priced at $0.78, while CANL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CANL's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CANL's ROE of +0.38%. Regarding short-term risk, ADMP is more volatile compared to CANL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, EAPH has a market cap of 93273.00. Regarding current trading prices, ADMP is priced at $0.78, while EAPH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas EAPH's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to EAPH's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to EAPH. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, KOAN has a market cap of 92369.00. Regarding current trading prices, ADMP is priced at $0.78, while KOAN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas KOAN's P/E ratio is -0.03. In terms of profitability, ADMP's ROE is +0.00%, compared to KOAN's ROE of +2.95%. Regarding short-term risk, ADMP is less volatile compared to KOAN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, POTN has a market cap of 90997.00. Regarding current trading prices, ADMP is priced at $0.78, while POTN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas POTN's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to POTN's ROE of +2.58%. Regarding short-term risk, ADMP is more volatile compared to POTN. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, IDCN has a market cap of 74079.00. Regarding current trading prices, ADMP is priced at $0.78, while IDCN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas IDCN's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to IDCN's ROE of N/A. Regarding short-term risk, ADMP is less volatile compared to IDCN. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ENDPQ has a market cap of 70566.00. Regarding current trading prices, ADMP is priced at $0.78, while ENDPQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ENDPQ's P/E ratio is -0.00. In terms of profitability, ADMP's ROE is +0.00%, compared to ENDPQ's ROE of +0.49%. Regarding short-term risk, ADMP is more volatile compared to ENDPQ. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, INLB has a market cap of 70181.00. Regarding current trading prices, ADMP is priced at $0.78, while INLB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas INLB's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to INLB's ROE of -0.42%. Regarding short-term risk, ADMP is more volatile compared to INLB. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HUGE has a market cap of 66671.00. Regarding current trading prices, ADMP is priced at $0.78, while HUGE trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HUGE's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to HUGE's ROE of -0.95%. Regarding short-term risk, ADMP is less volatile compared to HUGE. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, UNRV has a market cap of 58125.00. Regarding current trading prices, ADMP is priced at $0.78, while UNRV trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas UNRV's P/E ratio is -0.75. In terms of profitability, ADMP's ROE is +0.00%, compared to UNRV's ROE of +0.14%. Regarding short-term risk, ADMP is less volatile compared to UNRV. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CBGL has a market cap of 56821.00. Regarding current trading prices, ADMP is priced at $0.78, while CBGL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CBGL's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CBGL's ROE of +0.06%. Regarding short-term risk, ADMP is more volatile compared to CBGL. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HENC has a market cap of 55269.00. Regarding current trading prices, ADMP is priced at $0.78, while HENC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HENC's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to HENC's ROE of -154.80%. Regarding short-term risk, ADMP is more volatile compared to HENC. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, PAIOF has a market cap of 54872.00. Regarding current trading prices, ADMP is priced at $0.78, while PAIOF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas PAIOF's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to PAIOF's ROE of -0.09%. Regarding short-term risk, ADMP is less volatile compared to PAIOF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, OWCP has a market cap of 49750.00. Regarding current trading prices, ADMP is priced at $0.78, while OWCP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas OWCP's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to OWCP's ROE of +0.00%. Regarding short-term risk, ADMP is more volatile compared to OWCP. This indicates potentially higher risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, DZCA has a market cap of 49748.00. Regarding current trading prices, ADMP is priced at $0.78, while DZCA trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas DZCA's P/E ratio is -0.07. In terms of profitability, ADMP's ROE is +0.00%, compared to DZCA's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to DZCA. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, VFRM has a market cap of 49164.00. Regarding current trading prices, ADMP is priced at $0.78, while VFRM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas VFRM's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to VFRM's ROE of -2.44%. Regarding short-term risk, ADMP is less volatile compared to VFRM. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, TNRG has a market cap of 48786.00. Regarding current trading prices, ADMP is priced at $0.78, while TNRG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas TNRG's P/E ratio is 0.04. In terms of profitability, ADMP's ROE is +0.00%, compared to TNRG's ROE of +0.36%. Regarding short-term risk, ADMP is less volatile compared to TNRG. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, CNNC has a market cap of 48275.00. Regarding current trading prices, ADMP is priced at $0.78, while CNNC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas CNNC's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to CNNC's ROE of +0.00%. Regarding short-term risk, ADMP is less volatile compared to CNNC. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, ATTBF has a market cap of 47780.00. Regarding current trading prices, ADMP is priced at $0.78, while ATTBF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas ATTBF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to ATTBF's ROE of -0.27%. Regarding short-term risk, ADMP is less volatile compared to ATTBF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, FITX has a market cap of 46301.00. Regarding current trading prices, ADMP is priced at $0.78, while FITX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas FITX's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to FITX's ROE of -2.18%. Regarding short-term risk, ADMP is less volatile compared to FITX. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, HHPHF has a market cap of 45895.00. Regarding current trading prices, ADMP is priced at $0.78, while HHPHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas HHPHF's P/E ratio is -0.02. In terms of profitability, ADMP's ROE is +0.00%, compared to HHPHF's ROE of -1.55%. Regarding short-term risk, ADMP is less volatile compared to HHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, GEATF has a market cap of 44531.00. Regarding current trading prices, ADMP is priced at $0.78, while GEATF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas GEATF's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to GEATF's ROE of +17.27%. Regarding short-term risk, ADMP is less volatile compared to GEATF. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, QEBR has a market cap of 42572.00. Regarding current trading prices, ADMP is priced at $0.78, while QEBR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas QEBR's P/E ratio is -0.01. In terms of profitability, ADMP's ROE is +0.00%, compared to QEBR's ROE of -1.71%. Regarding short-term risk, ADMP is less volatile compared to QEBR. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.

ADMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ADMP stands at 7.25M. In comparison, SGBI has a market cap of 41980.00. Regarding current trading prices, ADMP is priced at $0.78, while SGBI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ADMP currently has a P/E ratio of -0.08, whereas SGBI's P/E ratio is N/A. In terms of profitability, ADMP's ROE is +0.00%, compared to SGBI's ROE of +0.05%. Regarding short-term risk, ADMP is less volatile compared to SGBI. This indicates potentially lower risk in terms of short-term price fluctuations for ADMP.